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ABSTRACT 
Edward Forrest Morrill: Posttraumatic Stress, Quality of Life, Depression, and Physical Health in 
Cancer Survivors: The Buffering Effect of Posttraumatic Growth 
(Under the direction of Karen M. Gil, Ph.D.) 
 
 
The current study attempted to use an online data collection system to replicate and extend  our 
previous findings on the interaction of posttraumatic growth and post-traumatic stress disorder (PTSD) 
symptoms in predicting depressive symptoms and quality of life in cancer survivors (Morrill et al., 2008).  
Participants were 165 survivors of a diverse range of cancers who completed an Internet-based 
questionnaire designed to assess perceived stress, PTSD symptoms, and posttraumatic growth, and three 
health outcomes (distress about physical health symptoms, quality of life, and depressive symptoms). The 
results of this study suggest that the online questionnaire is a feasible, efficient, reliable, and "user-friendly" 
tool to assess bio-psychosocial health factors in cancer survivors. PTSD symptoms were associated with 
more distress about physical health symptoms, poorer quality of life, and more depressive symptoms ; 
perceived stress was associated with more depressive symptoms ; and posttraumatic growth was associated 
with better quality of life (p < .01) and fewer depressive symptoms (p < .01). Results failed to support the 
hypothesized buffering effect of posttraumatic growth.  However, the interaction of PTSD symptoms and 
personal growth initiative accounted for a statistically significant(p < .05)  amount of the variance in quality 
of life  indicating a potential buffering effect of personal growth on the deleterious relation between 
posttraumatic stress and quality of life. Finally, of the 47 participants that reported clinically significant 
levels of depressive and/or PTSD symptoms only 27 (57%) reported being treated for a psychiatric 
disorder. Conclusions:. The findings of the current study indicate that as many as 10% of those suffering 
from cancer may have clinically significant PTSD symptoms which are associated with poorer health 
outcomes. Only 57% of the cancer survivors in the current study who reported clinically significant 
symptoms of PTSD or depression reported receiving treatment for a psychiatric disorder. These results 
highlight the importance of screening for PTSD and depression in cancer patients and survivors in both 
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research and clinical settings, followed by referral for diagnostic assessment and subsequent treatment 
when appropriate. Additionally, Internet-based data collection may have important implications regarding 
screening, referral, and ongoing assessment of psychological distress in clinical care. 
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INTRODUCTION 
Distressing or harmful events can lead to negative outcomes such as posttraumatic stress symptoms, 
but these events can also lead to positive outcomes, an experience termed posttraumatic growth (Cordova 
& Andrykowski, 2003). In the context of a cancer diagnosis, posttraumatic growth may improve important 
psychological outcomes, including depression, positive well-being, health behaviors, and positive affect 
(Stanton, Bower, & Low, 2006).  However, posttraumatic growth may also offer more complex benefits 
that have been previously unexplored (Helgeson, Reynolds, & Tomich, 2006).  This study of cancer 
survivors examined the possibility that posttraumatic growth may offset some deleterious correlates of 
posttraumatic stress. 
This cross-sectional study will investigate the relationship of perceived stress, posttraumatic stress 
symptoms, and posttraumatic growth to quality of life, depressive symptoms, and physical health. The 
current study attempted to replicate my previous findings on the interaction of posttraumatic growth and 
posttraumatic stress symptoms in predicting depressive symptoms and quality of life in cancer survivors 
(Morrill et al., 2008) and extend the prediction to physical health symptoms.  Moreover, this study will 
utilize an online data collection system and include a more diverse sample of cancer survivors. In order to 
provide the relevant background for the study, this introduction will briefly summarize the research on 
stress, posttraumatic stress symptoms, posttraumatic growth, psychological health, and physical health 
especially as they relate to cancer survivorship. In addition, given that the study incorporates a newly 
designed internet-based data collection system, the introduction will include a brief review of electronic 
data collection methodologies as they relate to health psychology research. 
Cancer Survivorship  
The term “cancer” refers to a conglomerate of separate but related diseases with an underlying 
similarity, namely, uncontrolled cell growth (National Cancer Institute, 2007b).  This uncontrolled cell 
growth can be detrimental to the body in different ways such as damaging tissue and hindering normal 
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body processes including digestion, cardiovascular function, and neurological function (American Cancer 
Society, 2010).    
As of January 1 2008 the National Cancer Institute estimated there were 12 million cancer survivors 
living in the United States (National Cancer Institute, 2011b) representing approximately 4% of the 
population. According to the National Cancer Institute (2010), an estimated 1.5 million new cancer cases 
are diagnosed each year.  Furthermore, 65% of adults diagnosed with cancer in recent years will survive for 
five years or more (National Cancer Institute, 2011b).  Among the most common cancers in adults are lung, 
prostate, breast, and colorectal, although more than 200 types of cancer have been identified (National 
Cancer Institute, 2007a). 
  The most common forms of treatment for cancer are surgery, irradiation, and chemotherapy 
(National Cancer Institute, 2011a). Depending on the type of cancer and treatment protocol, cancer patients 
often experience unpleasant side effects of treatment including nausea, hair loss, fatigue, and cognitive 
deficits (Kangas, Henry, & Bryant, 2002).  Following the active treatment phase, most cancer patients with 
life threatening disease attend regular follow-up appointments and many begin adjuvant medical therapies.   
The physical and psychological challenges associated with the diagnosis and treatment of cancer are 
well documented (Bleiker, Pouwer, van der Ploeg, Leer, & Ader, 2000; Pettingale, Burgess, & Greer, 1988; 
Sherliker & Steptoe, 2000; Smith, Redd, Peyser, & Vogl, 1999; Trask, Paterson, Fardig, & Smith, 2003).  
Given the challenges facing cancer patients during the active phase of treatment, patients commonly 
experience stress, anxiety, fear of death, and other psychosocial consequences. Indeed, regular visits to the 
treatment setting can act as an ongoing reminder of diagnosis and treatment and may extend the cancer 
experience for many months and potentially years (Gil, Mishel et al., 2004; Smith, Redd, Peyser et al., 
1999).   
Additionally, depressive symptoms and lower quality of life are concerns for long-term survivors 
(Edelman, Bell, & Kidman, 1999). Although rates of clinical depression are not higher in long-term cancer 
survivors compared to healthy controls (Gotay, Isaacs, & Pagano, 2004), sub-syndromal depressive 
symptoms and poorer quality of life remain important adverse effects of cancer (Cordova et al., 1995; 
Cordova, Cunningham, Carlson, & Andrykowski, 2001b; Zabora, Brintzenhofeszoc, Curbow, Hooker, & 
Piantadosi, 2001).  In one study, 18% of breast cancer survivors reported clinically significant levels of 
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psychological distress (Zabora et al., 2001).  Previous research has indicated that as many as 39% of cancer 
patients meet criteria for a psychiatric disorder (Derogatis et al., 1983; Mehnert & Koch, 2007).  According 
to Derogatis and colleagues (1983) the vast majority of patients who meet criteria for a psychiatric disorder 
suffered from depression, anxiety or both.  
Many cancer survivors also continue to have fatigue, pain, swelling, and acute illnesses, and these 
difficulties are sometimes prolonged for years following active treatment (Abercrombie et al., 2004; 
Golden Kreutz, Browne, Frierson, & Andersen, 2004; National Cancer Institute, 2007b).  In recognition of 
the significance of cancer survivorship, in 1996 the Office of Cancer Survivorship of the National Cancer 
Institute (NCI) was established for the purpose of enhancing the length and quality of life of the estimated 
8.9 million cancer survivors in the United States and for addressing their unique and poorly understood 
needs (National Cancer Institute, 2007c). The NCI Office of Cancer Survivorship supports research in the 
areas of physical effects of disease and treatment, psychosocial factors, health disparities, intervention, 
family issues, financial burden, and communication among cancer survivors. The recent focus on 
understanding the needs of cancer survivors has led to psychosocial research in the areas of quality of life, 
perceived stress, depression, and anxiety (Brown, Madan-Swain, & Lambert, 2003; Carlson, Speca, Patel, 
& Goodey, 2003; Drageset & Lindstrom, 2003; Giovagnoli, 1999; Trask et al., 2003). Cancer survivorship 
research has also focused on cognitive function, fatigue, physical activity, spiritual/religious activity, and 
physical health (Bardwell et al., 2004; Cordova, Cunningham, Carlson, & Andrykowski, 2001a; Iconomou, 
Mega, Koutras, Iconomou, & Kalofonos, 2004; Mock et al., 2001). 
Health psychology research in cancer survivorship has paralleled the research in other chronic diseases 
in that investigators have not only tried to document the specific physical and psychosocial consequences 
of the cancer experience but also, more importantly, have tried to identify the significant predictors of 
physical and psychosocial adjustment. As in research with other chronic diseases, stress has emerged as a 
potentially meaningful predictor of adjustment for cancer survivors (L. Cohen, Marshall, Cheng, Agarwal, 
& Wei, 2000; Forlenza, Latimer, & Baum, 2000; Porter et al., 2003). As Dr. George L. Engel pointed out 
more than 30 years ago in his challenge to biomedicine, physical health outcomes ranging from serious 
chronic illness to the common cold occur in the context of a complex interaction of physiological, 
psychological, and socio-cultural variables (Engel, 1977). This viewpoint, commonly referred to as the bio-
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psycho-social model, is the underlying basis of much of the current health psychology research (Lillie et 
al., 2007; Morrill et al., 2008; Morrill, Richardson, Keith, & Puente, 2006; O'Neill et al., 2007; Panter & 
Reeve, 2002), including the current study and many studies recently conducted by our laboratory (Gil et al., 
2001; Gil et al., 2003; Gil, Carson et al., 2004).  
Stress  
From a theoretical perspective, there have been several major contributors to the way stress is 
conceptualized, including Hans Selye, Richard Lazarus, and Susan Folkman. Selye originally 
conceptualized stress as a stimulus or event; examples include an overbearing boss, being cut off in traffic, 
getting married or divorced, or the loss of a loved one. However, by the 1950’s his research began to focus 
on stress as a response to a stimulus. He coined the term “stressor” to indicate the environmental stimulus 
and used the word “stress” to indicate the response to the stimulus (Selye, 1956, 1976, 1982).  
Selye’s concept of the stress response evolved into the General Adaptation Syndrome (GAS), which 
emphasizes the physiological changes that occur during stress -- increased respiration and heart rate, 
increased secretion of adrenaline, and decreased gastrointestinal activity, among other physiological 
responses. The GAS consists of three phases: the alarm stage during which the body responds to a stressor 
in ways that lower its resistance to disease; the resistance stage during which the body gears up in order to 
protect against the effects of the stressor; and the exhaustion stage during which chronic stress often exerts 
its deleterious effects on physical and psychological health (Selye, 1982).  Though revolutionary at the 
time, Selye’s viewpoint on stress was limited in its presumption that stress was “event-based” and that a 
given stressor would uniformly elicit the same general physical response.   
Lazarus and Cohen (1977) proposed a model incorporating three general levels of stressors: 
cataclysmic events; major life events, and daily hassles. Cataclysmic refer to events such as natural 
disasters including earthquakes, fires, and floods, as well as war. Major life events include experiences such 
as unemployment, divorce, or diagnosis with a serious illness. Daily hassles include day-to-day stressors 
such as traffic, problems at work, and too many responsibilities. Kanner and colleagues (1981) emphasized 
the importance of daily hassles and further conceptualized and integrated a model that incorporated 
measurement of minor stressors as they accumulate over time into stress research.  
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Stress and Perceived Stress 
According to Richard Lazarus, a person’s interpretation (appraisal and perception) of a stressor and 
their available coping resources are more important than the stressor itself (Lazarus, 1984, 1993).  Lazarus 
and Folkman (1984) posit that stress can be characterized as a transactional relation among a person’s 
appraisal of, vulnerability to, and ability to cope with an internal or external stressor. According to Lazarus 
and Folkman, appraisal consists of three phases: a primary appraisal during which a person appraises the 
meaning of the situation as stressful, positive, benign, or irrelevant; a secondary appraisal when a person 
assesses their ability to deal with the stressor; and then reappraisal when a person constantly re-appraises 
the meaning of a situation and their ability to deal with it as new information becomes available. Likewise, 
coping refers to a person’s ability to utilize the psychological, physical, and social resources to manage the 
stressor (Lazarus & Folkman, 1984).  Vulnerability refers to the degree to which a person’s subjectively 
perceived underlying psychological, physical, or social state makes them more or less susceptible to 
adverse outcomes resulting from a stressor (Lazarus & Folkman, 1984). 
The term “perceived stress” was coined by Cohen and Williamson (1988) and is meant to encompass 
the concept that stress is not inherently a result of any particular stressor (event or situation-based) but 
rather a person’s appraisal of whether or not the threat of a given stressor is greater than the resources 
available to cope with the stressor. Stress has succinctly been described as a “give-and-take” interaction 
between a person and their environment (Folkman, Lazarus, Gruen, & DeLongis, 1986).  The term anxiety 
refers to and is often used interchangeably with the overlapping construct, stress. Signs of anxiety include 
psychological symptoms (feelings of fear, agitation, and apprehension) and physical symptoms (trembling, 
muscle tension, headaches, sweating, dry mouth, difficulty swallowing) which may be a result of persistent 
and unrelenting stress (National Institutes of Health, 2008). Additionally, the experience of specific 
combinations of anxiety symptoms can indicate meeting diagnostic criteria for  a Diagnostic and Statistical 
Manual of Mental Disorders Fourth Edition (DSM-IV) axis I anxiety disorder, such as panic disorder, acute 
stress disorder, obsessive compulsive disorder, and posttraumatic stress disorder (Abramowitz, Taylor, & 
McKay, 2008; American Psychiatric Association, 1994).  According to psychophysiological theories, the 
interaction between a person and their environment, characterized by stress, causes physiological changes 
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such as increased secretion of adrenaline, increased respiration, increased heart rate, and potentially 
hypertension.  
The two primary physiological mechanisms responsible for eliciting and regulating the stress response 
and influencing physical and psychological functioning are the hypothalamic-pituitary-adrenal axis (HPA 
or HTPA axis) and the sympathetic-adrenomedullary (SAM) axis (Salovey, Rothman, Detweiler, & 
Steward, 2000; Stone, Reed, & Neale, 1987; Vermetten & Bremner, 2002).  Research has found that 
chronic activation of the SAM axis affects physical health through a relative decrease in antibodies such as 
secretory immunoglobulin A (S-IgA), which is thought to defend against illness (Salovey et al., 2000). 
Similarly, research in both animals and humans has demonstrated an association between chronic activation 
of the HPA axis and symptoms of anxiety and mood disorders such as posttraumatic stress disorder (PTSD) 
and depression (Fuchs, Czeh, & Flugge, 2004; Vermetten & Bremner, 2002; Vermetten, Vythilingam, 
Southwick, Charney, & Bremner, 2003). The stress response, although adaptive during acute periods of 
activation, can also lead to the development of illness and exacerbation of physical and psychological 
symptoms (S. Cohen, Tyrrell, & Smith, 1993; DeLongis, Folkman, & Lazarus, 1988; Gil, Carson et al., 
2004; Morrill et al., 2008; Morrill et al., 2006; Reibel, Greeson, Brainard, & Rosenzweig, 2001).  
Stress and Physical Health  
Stress has been associated with physical health symptoms in a multitude of health problems including 
HIV/AIDS, cardiovascular disease, gastrointestinal disorders, musculoskeletal disorders, pain conditions, 
influenza, and the common cold (Carson, 1999; S. Cohen et al., 1993; DeLongis et al., 1988; Pereira et al., 
2003; Takkouche, Regueira, & Gestal-Otero, 2001).  For example, Pereira and colleges (2003) reported that 
stress was a significant predictor of genital herpes recurrence among 34 HIV+ African American women.  
DeLongis and colleagues (1988) reported an association between stress and health problems among 75 
married couples who participated in a repeated-measure design study. Specifically, they reported that daily 
stress was associated with same- and subsequent-day backaches, headaches, sore throats, and influenza. 
Among faculty and staff at a university in Spain, Takkouche and colleagues (2001) found that higher levels 
of perceived stress and negative affect, as well as more stressful life events, were all independently 
associated with an increased risk of occurrence of the common cold. Likewise, Cohen, Tyrrell, and Smith 
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(1993) reported that higher stress was associated with a greater risk of developing a common cold in 
otherwise healthy individuals.   
Stress has also emerged as a predictor of immune function (Glaser et al., 1992) and DNA repair 
capacity (L. Cohen et al., 2000; Glaser, Thorn, Tarr, Kiecolt-Glaser, & D'Ambrosio, 1985).  In a sample of 
48 second-year medical students, Glaser, and colleagues (1992) found that having less stress was related to 
a more functional immune system, as measured by immune response to inoculation for hepatitis B. Cohen 
and colleagues (2000) studied the effect of exam stress in 16 first- and second-year medical students. They 
report that exam stress caused elevations in DNA repair capacity (DRC), a potential measure of DNA 
damage, and perceived stress. Forlenza, Latimer, and Baum (2000) reported that among professional 
students (i.e., medical, dental, pharmacy, and law), both DRC and perceived stress were higher during the 
stressful exam period when compared with a non-stressful end-of-vacation assessment.  
Within the context of cancer, research has demonstrated that cancer survivors have altered 
physiological responses that may be due to prolonged stress from their illness (Gurevich et al., 2004; Porter 
et al., 2003).  In one study, Porter and colleagues found that breast cancer survivors had a higher baseline 
cortisol level and experienced a reduction in cortisol levels from baseline to the mammography period 
whereas healthy controls had an increase in cortisol levels for the same stressful period of time. These 
findings suggest that chronic stress resulting from the cancer experience may lead to heightened baseline 
levels of physiological arousal and may suppress typical patterns of physiological reactions in acute 
stressful situations.   
Taken together, these results suggest that stress affects physical health in complex ways. It also seems 
possible that the cumulative stress caused by low intensity stressors and frustrations in daily life layered 
upon the stress from a major life event, such as the cancer experience, may result in the exacerbation of an 
already dysfunctional stress response, thereby augmenting physical health problems.  
Posttraumatic Stress 
The stress of the cancer experience has been linked to the development of posttraumatic stress disorder 
(PTSD; Green et al., 1998; Smith, Redd, Peyser et al., 1999). The Diagnostic and Statistical Manual of 
Mental Disorders, Fourth Edition (DSM-IV) (American Psychiatric Association, 1994) defines PTSD as an 
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anxiety disorder that occurs following a traumatic event that involved actual or threatened death or a threat 
to one’s physical integrity or that of others, and which evoked intense fear, helplessness or horror. 
Diagnostic criteria include three symptom clusters: re-experiencing in the form of recurrent and intrusive 
thoughts, avoidance of or numbing in response to trauma-related stimuli, and increased physiological 
arousal. Criteria must be met for at least one month and cause clinically significant distress or impairment.       
The DSM-IV expanded events capable of eliciting a response of PTSD, when compared to previous 
editions, to include life-threatening illnesses such as cancer. The events that unfold during a cancer 
diagnosis and subsequent treatment are capable of producing symptoms of posttraumatic stress disorder 
(Green et al., 1998; Kangas et al., 2002). PTSD and sub-syndromal posttraumatic stress symptoms are 
associated with higher rates of depression, anxiety disorders, and lower quality of life among cancer 
patients and survivors (Cordova et al., 1995; Morrill et al., 2008; Schwartz & Drotar, 2006).  Cancer 
survivors who experience posttraumatic stress symptoms also appear to experience negative physical health 
outcomes, suggesting the need to examine the relationship between posttraumatic stress and physical health 
symptoms (Barakat, Kazak, Gallagher, Meeske, & Stuber, 2000; Hegel et al., 2006; Schwartz & Drotar, 
2006).  For example, Schwartz and Drotar (2006) explored the relations between PTSD and psychological 
and physical health outcomes among childhood cancer survivors.  They reported that higher levels of 
posttraumatic stress symptoms were associated with worse psychosocial and health outcomes including 
poorer mood, more depressive symptoms, and worse health-related quality of life (HRQOL) when 
compared with those with fewer posttraumatic stress symptoms.   
While a diagnosis of PTSD is somewhat rare among patients with some types of cancer (Kangas et 
al., 2002), posttraumatic stress symptoms may occur in up to 50% of all cancer patients (Gurevich et al., 
2004). Considering the potentially deleterious effects of posttraumatic stress symptoms and the fact that 
incidence of cancer diagnosis continues to rise in the United States, cancer-related symptoms of PTSD have 
the potential to negatively impact the lives of thousands of people every year (American Cancer Society, 
2007).  
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Posttraumatic Growth  
 Although people who experience traumas such as loss of a loved one or serious illness 
can suffer negative bio-psycho-social consequences, they often report positive psychosocial outcomes from 
trauma. This experience, termed posttraumatic growth, may include feeling more fully satisfied with life, 
and/or having an improved quality of life after successfully navigating the traumatic event or experience 
(Stanton et al., 2006; Taylor, 1983; Tedeschi, Park, & Calhoun, 1998). Dimensions of posttraumatic growth 
include enhanced interpersonal relationships, greater appreciation for life, increased spirituality, sense of 
increased personal strength, and valued change in life priorities or goals (Tedeschi & Calhoun, 1996). 
According to relevant theories (Janoff-Bulman & Frantz, 1997), posttraumatic growth may represent an 
attempt to understand the value or meaning that the trauma has had in one’s life.  This process can help to 
minimize feelings of loss and to enhance a sense of purpose and meaning in life (Nolen-Hoeksema & 
Davis, 2002; Taylor, 1983).  
According to Tedeschi and Calhoun (2004) posttraumatic growth is a psychosocial process that 
effectively transforms automatic, intrusive, and negative ruminations into growth-oriented and positive 
narrative-developing intentional thoughts.  This transformation is accomplished by reducing the effect of 
emotional distress, management of automatic rumination, and reducing the effect of unwanted schema 
change. All of these transitions are brought about by a combination of internal and external self-disclosure, 
positive social support, active coping, cognitive reframing, and when necessary, as is often the case with 
chronic illness-related posttraumatic stress, disengagement from previous goals and incorporation of 
revised life goals.  
Measuring Posttraumatic Growth.  According to Park and Lechner (2006), three psychometrically 
validated measures are currently in use to assess positive change resulting from a traumatic experience. 
They are the Stress Related Growth Scale (SRGS; Park, Cohen, & Murch, 1996), the Posttraumatic Growth 
Inventory (PTGI; Tedeschi & Calhoun, 1996), and the Benefit Finding Scale (BFS; Antoni et al., 2001). 
From a conceptual standpoint, the measures are very similar and are psychometrically comparable. All 
three are retrospective and have major shortcomings in part due to the incorporation of cognitions, feelings, 
and behaviors in a single construct.  
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Regarding reliability and validity, the SRGS has demonstrated adequate internal-reliability coefficient 
of .94 with two week test-retest of .81 (Park et al., 1996); the BFS has demonstrated an internal-reliability 
coefficient of .95 with no test-retest reliability reported (Antoni et al., 2001). The PTGI has demonstrated 
an internal-reliability coefficient of .90 with adequate subscale internal reliability ranging from .67 to .85 
and adequate test-retest reliability (r=.71) ( Tedeschi & Calhoun, 1996).  Logistically the PTGI is shorter 
(21 items) than the SRGS (50 items) and only slightly longer than the BFS (17 items); the PTGI is more 
widely used than the other two scales. 
Posttraumatic Growth and Personal Growth 
Personal growth has been described as an important process that produces positive personal change 
and development. Developmental, environmental, and intentional events and processes can act as a catalyst 
for continued personal growth across the lifespan (Robitschek, 1998). Cancer diagnosis, treatment, and 
survivorship could be viewed as an example of an environmental experience that has the potential to foster 
ongoing personal growth. When personal growth is stimulated by a traumatic environmental event or 
process such as the cancer experience, it is often referred to as posttraumatic growth or benefit finding 
(Tedeschi & Calhoun, 1995; Widows, Jacobsen, Booth-Jones, & Fields, 2005). For example, in their 
discussion of trauma and transformation Tedeschi and Calhoun (1995) indicate that this type of personal 
development can be triggered by traumatic experiences such as cancer diagnosis, treatment, and 
survivorship.  With regard to how posttraumatic growth compares and contrasts with other similar 
constructs from positive psychology including optimism, resilience, hardiness, and sense of coherence, 
Tedeshi and Calhoun (2004) make compelling arguments that posttraumatic growth and these positive 
psychology constructs differ conceptually in important ways. Generally, the positive psychology constructs 
describe characteristics related to coping with adversity well, whereas posttraumatic growth refers to a 
significant change in the way a person views the world and their life. This shift in schema not only allows a 
person to cope with adversity, but also to grow from it such that they exceed their pre-trauma level of 
functioning.  
Posttraumatic Growth and Cancer 
In the area of medical illnesses, researchers have found that survivors of heart attack, HIV infection, 
and other serious medical conditions such as cancer can experience both posttraumatic stress and 
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posttraumatic growth (Affleck & Tennen, 1996; Cordova & Andrykowski, 2003; Cordova et al., 2001a; 
Ho, Chan, & Ho, 2004; Morrill et al., 2008; Schulz & Mohamed, 2004). Between 60% and 95% of cancer 
survivors report posttraumatic growth as a result of a cancer diagnosis, treatment, and survivorship (Stanton 
et al., 2006).  
Over the last decade, interest has increased in research exploring the positive life changes that 
cancer survivors report following diagnosis and treatment (Bellizzi et al., 2010; M. Cohen & Numa, 2011; 
Cordova et al., 2001a; Cordova et al., 2007; Helgeson et al., 2006; Lelorain, Bonnaud-Antignac, & Florin, 
2010; Love & Sabiston, 2011; Mols, Vingerhoets, Coebergh, & van de Poll-Franse, 2009; Porter et al., 
2006; Salsman, Segerstrom, Brechting, Carlson, & Andrykowski, 2009; Sears, Stanton, & Danoff-Burg, 
2003; Stanton et al., 2006; Widows et al., 2005). For example, Cordova and colleagues (2001a) report that 
breast cancer survivors experience increased posttraumatic growth in areas of relating to others, 
appreciation of life, and spiritual change.  Correlates of posttraumatic growth among cancer patients and 
survivors include demographic characteristics (socioeconomic status, ethnicity, and age), personality 
variables (optimism and positive personality resources, and approach-oriented coping), and psychological 
well-being (greater positive affect and less depression) (Helgeson et al., 2006; Stanton et al., 2006). 
However, studies have also reported inconclusive results or a lack of association with posttraumatic growth 
and perceived threat, disease severity, time since diagnosis, type or amount of treatment, marital status, 
avoidant-based coping, psychological distress, and quality of life (Helgeson et al., 2006; Stanton et al., 
2006).  
Some researchers have approached posttraumatic growth as an outcome and sought to explore 
associations with various predictors such as cognitive reframing, rumination, coping, emotional regulation, 
psychological adjustment, and religious involvement (Calhoun, Cann, Tedeschi, & McMillan, 2000; Porter 
et al., 2006; Wild & Paivio, 2003). Others have viewed it as a predictor and sought to design interventions 
aimed at increasing the likelihood of positive psychosocial outcomes resulting from potentially traumatic 
events through the mechanism of posttraumatic growth (Calhoun & Tedeschi, 2000). It is perhaps for these 
reasons that research of this construct has produced somewhat ambiguous and inconsistent results 
especially with regard to overall or general quality of life and psychological distress (Cordova & 
Andrykowski, 2003; Linley & Joseph, 2004).  
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Cordova and Andykowski (2003) argued that it is possible to experience cancer diagnosis, treatment, 
and survival as a trauma and transition, potentially leading to both positive and negative psychosocial 
outcomes (Cordova & Andrykowski, 2003). Posttraumatic growth is one example of the potentially 
positive outcomes of cancer diagnosis and treatment. As previously mentioned, posttraumatic stress 
symptoms have been shown to be associated with depression, poorer quality of life, and poorer physical 
health. However, posttraumatic growth has not been consistently demonstrated to be directly associated 
with psychological distress, quality of life or physical health.  
The interaction between posttraumatic stress symptoms and posttraumatic growth and other bio-
psychosocial constructs may be an additional reason for previous mixed findings (Morrill et al., 2008).  
Several previous studies have explored posttraumatic growth in moderation models with time since 
diagnosis, the nature of the stressor, posttraumatic stress, quality of life, depressive symptoms, intrusive 
thoughts, adjustment, social support, enduring distress and physical activity (Helgeson et al., 2006; Morrill 
et al., 2008; Park, Chmielewski, & Blank, 2010). For example, Park and colleagues (2010) report a 
buffering effect of posttraumatic growth on the relations between intrusive thoughts and spiritual well-
being, life satisfaction, and negative affect. Thus, one possible explanation for the inconsistent results 
regarding posttraumatic growth may be an indirect association in the form of a moderation of the 
deleterious relation between posttraumatic stress symptoms and health among cancer patients.   
The Buffering Effect of Posttraumatic Growth 
My previous research bolsters the assertion that posttraumatic stress symptoms and posttraumatic 
growth can manifest simultaneously in the cancer experience and that the experience of posttraumatic 
growth ameliorates the deleterious relationships between posttraumatic stress symptoms and both quality of 
life and depressive symptoms (Morrill et al., 2008). I hypothesized that posttraumatic growth may act as a 
coping resource that protects cancer patients against the corrosive effects of PTSD on quality of life and 
depressive symptoms. Although posttraumatic growth may not successfully uproot the intrusive thoughts 
and cognitions that accompany PTSD, it may provide a positive buffer. More specifically, posttraumatic 
growth may reflect cognitive adaptation in response to cancer diagnosis (e.g., a positive reinterpretation) 
that can alter the global meaning of the cancer experience (Helgeson et al., 2006). Similar cognitive 
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reappraisal has been demonstrated to reduce the effect of posttraumatic stress symptoms on psychological 
distress in breast cancer survivors (Vickberg, Bovbjerg, DuHamel, Currie, & Redd, 2000).   
Studies of the relation of posttraumatic growth to well-being have found inconsistent results (Helgeson 
et al., 2006). Several hypotheses may explain these inconsistencies, including varying levels of 
posttraumatic stress symptoms and posttraumatic growth within individuals. Cordova and Andrykowski 
(2003) argue that experiencing cancer-related stress and growth simultaneously is possible because people 
often view the experience as both a trauma and transition to a new phase in their lives.  
Because cancer diagnoses can cause great distress, it is not surprising that some cancer survivors have 
elevated levels of posttraumatic stress symptoms that are associated with depressive symptoms, lower 
quality of life, and poorer physical health. My  previous research has demonstrated a buffering effect of 
posttraumatic growth on the relation between posttraumatic stress symptoms and both quality of life and 
depressive symptoms among breast cancer survivors (Morrill et al., 2008). 
In my study, we assessed posttraumatic growth using the Posttraumatic Growth Inventory, 
posttraumatic stress symptoms using the PTSD Checklist, depressive symptoms using the CES-D, and 
quality of life using the FACT-B (Morrill et al., 2008). Participants were 161 women previously treated for 
early stage breast cancer. Results indicated that higher levels of posttraumatic stress symptoms predicted 
greater depressive symptoms and lower quality of life (p < .01). The relation between posttraumatic stress 
symptoms and depression was attenuated among women with higher levels of posttraumatic growth, as 
evidenced by the interaction of posttraumatic stress symptoms and posttraumatic growth (p < .05). A 
similar interaction was found with regard to quality of life (p < .01), with posttraumatic growth weakening 
the posttraumatic stress symptoms - quality of life relationship. Although not reported in the original 
manuscript, when using the physical well-being subscale of the FACT-B as an analogue for physical health, 
a similar pattern of results was evident with posttraumatic growth weakening the posttraumatic stress 
symptoms - physical health relationship. The physical well-being scale of the FACT-B (FACT-B-PWB) 
assesses seven aspects of physical well-being pertinent to cancer patients and survivors on a 5-point scale 
ranging from 0 (not at all) to 4 (very much). The specific items of the FACT-B-PWB scale are: “I have a 
lack of energy”; “I have nausea”; “Because of my physical condition, I have trouble meeting the needs of 
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my family”; “I have pain”; “I am bothered by side effects of treatment”; “I feel ill”; and “I am forced to 
spend time in bed.”  
When taken as a whole, results of the previously mentioned studies make clear three pertinent 
ideas. First, although most cancer survivors experience some negative bio-psycho-social sequelae of cancer 
diagnosis, treatment, and survivorship, many experience positive sequelae (such as posttraumatic growth). 
Second, these positive sequelae have the potential to ameliorate the deleterious effect of at least a portion of 
the negative sequelae (such as posttraumatic stress symptoms) as they relate to quality of life and 
depressive symptoms. Third, this buffering effect is likely to remain true with regard to physical health 
symptoms.  
Conceptual Model of the Buffering Effect of Posttraumatic Growth  
To conceptualize the mechanism by which posttraumatic growth buffers the relation between 
posttraumatic stress and health outcomes among cancer patients and survivors, it is necessary to briefly 
review the four components involved. Specifically, I will outline theoretical underpinnings for the relation 
between the traumatic experience of cancer diagnosis, treatment and survivorship and posttraumatic stress 
symptoms; the association between posttraumatic stress symptoms and health outcomes; the processes 
involved in the experience of posttraumatic growth; and the buffering effect of posttraumatic growth on the 
deleterious relation between posttraumatic stress and health outcomes among cancer patients and survivors.  
 Cancer and posttraumatic stress.  Traumatic experiences such as diagnosis and treatment of 
cancer can cause a profound shift in a person’s schema, and subsequent conflict between a person’s pre-
trauma sense of self and world view and their post-trauma sense of self and world view. For example, prior 
to the experience of a trauma, such as being diagnosed with potentially lethal cancer, a person may believe, 
as part of their underlying schema, that the world is a relatively predictable place, that they have control 
over the course their life; and that plans they have made for the future will come to pass. Whereas 
following diagnosis and treatment they may begin to realize, as a result of their cancer experience, that the 
world is not as predictable as they once believed, that they have less control over the course their life will 
take than they once thought, that the plans they have made may not come to pass. This disparity can be 
extremely distressing and  may lead directly to psychological distress as well as indirectly to increased 
physiological arousal through stimuli that remind them of the trauma of diagnosis and treatment including 
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negative cognitions, rumination, intrusive thoughts, ongoing medical appointments, concerns about the 
future, and  uncertainty about recurrence. Additionally, this response to profound schema change may lead 
to increased negative psychological responses (i.e. anxiety, negative affect, intrusive thoughts, catastrophic 
thinking, posttraumatic cognitions, rumination, and intrusive thoughts) and dysregulation of one's stress 
response systems. The combination of maladaptive cognitions and dysregulation of the stress response 
systems has the potential to lead to an increase in posttraumatic stress symptoms. 
 Posttraumatic stress symptoms and health. I hypothesize that the deleterious effect of 
posttraumatic stress symptoms on both psychological and physical health results from the intense and often 
unremitting psycho-physiological response to  traumatic experiences  (both by maladaptive cognitions, 
negative affect and ruminations as well as the labeling of these responses as discordant with one’s preferred 
or pre-trauma sense of self). I further theorize that the mechanisms by which posttraumatic stress leads to 
negative psychological outcomes potentially occur through four major pathways. Specifically, there is a 
direct link from (1) the experience of profound unresolved schema change, (2) re-experience/rumination of 
or about the traumatic experience, (3) avoidance of stimuli that remind one of the trauma, and (4) 
physiological arousal with subsequent experience of anxiety, and depression. With regard to the negative 
effect of posttraumatic stress on physical health outcomes I believe there are two primary mechanisms. 
First is the direct effect of prolonged physiological hyper-arousal on physical health. As outlined above this 
occurs through several physiological processes including prolonged activation of the hypothalamic-
pituitary-adrenal axis (HPA or HTPA axis) and the sympathetic-adrenomedullary (SAM) axis. The second 
potential pathway by which posttraumatic stress can affect negative physical health outcomes is via 
negative health behaviors. Specifically, posttraumatic stress has the capacity to affect physical health 
through failure to engage in health promoting behaviors such as treatment adherence and attending follow-
up appointments with health care providers, and engaging in unhealthy behaviors including substance use, 
lack of exercise, poor diet, and not getting sufficient sleep.  
The process of posttraumatic growth. The current study builds on the model of posttraumatic growth 
put forth by Calhoun and Tedeschi. According to Tedeschi and Calhoun (2004) posttraumatic growth is a 
psychosocial process that effectively transforms automatic, intrusive, and negative ruminations into 
deliberate, growth oriented, narrative developing ruminations.  This transformation is accomplished by 
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reducing the effect of emotional distress, management of automatic rumination, and reducing the effect of 
unwanted schema change. All of these transitions are brought about by a combination of internal and 
external self disclosure, positive social support, active coping, cognitive reframing, and when necessary, as 
is often the case with chronic illness related posttraumatic stress, disengagement from previous goals and 
incorporation of revised life goals.  
 Posttraumatic growth, posttraumatic stress, and health. In summary I theorize that the process 
of transforming automatic, intrusive and negative rumination into deliberate, growth oriented, life narrative 
developing ruminations ultimately results in a reduction of the effect of posttraumatic stress on health 
outcomes both directly and indirectly by facilitating adaptation to changes in a person’s schema and 
reducing the effect of re-experience, avoidance and physiological arousal.  Although, this reduction does 
not result in complete abatement of the effects of posttraumatic stress or the ensuing distress, as evidenced 
by the simultaneous occurrence of both posttraumatic growth and stress, it is theorized that the reduction is 
sufficient to ameliorate a portion of the negative health outcomes resultant from the experience of trauma 
and subsequent posttraumatic stress response.  
Internet-Based Data Collection  
As access to the internet increases, the use of Internet-based data collection methods has become more 
common (e.g. Bauer et al., 2004; Bliven, Kaufman, & Spertus, 2001; Fergusson, Hendry, & Freeman, 
2003; Metzger, Kristof, & Yoest, 2003; Park, Armeli, & Tennen, 2004; Ritter, Lorig, Laurent, & Matthews, 
2004; Whybrow et al., 2003). Several studies have set out to establish psychometric validity for the online 
data collection methodology and compared it directly with the more traditional paper and pencil method of 
data collection (Bliven et al., 2001; Metzger et al., 2003; Ritter et al., 2004). For example Ritter, Lorig, 
Laurent, and Matthews (2004) compared patterns of response on 16 self-report measures administered 
using an online versus paper and pencil methodology. They report that among 397 chronically-ill 
participants there were no significant psychometric differences in 14 of the 16 self-report psychological and 
physical health-related measures completed. Bliven and colleagues (2001) sought to explore the reliability 
and validity of a cross-sectional Internet-based health-related quality of life measure. They reported that in 
a sample of 55 cardiology outpatients, greater than 80% preferred the internet-based collection over the 
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paper and pencil versions, nearly 90% were comfortable using the application without additional technical 
support, and that data collected using electronic and paper and pencil versions were consistent (Bliven et 
al., 2001). Additionally, in the area of face recognition, Metzger and colleagues (2003) reported that among 
college students, online and paper and pencil methodologies yielded similar results. Studies such as these 
indicate that internet-based data collection is a valid, reliable, and often preferable method for collecting 
data.  
In addition to being valid, reliable and often preferable, research has demonstrated that internet-
based data collection has many additional benefits (Bauer et al., 2004; Bliven et al., 2001; Granello & 
Wheaton, 2004; Schillewaert & Meulemeester, 2005). Internet-based data collection and management is 
inherently more efficient when compared to paper and pencil methodologies (Bliven et al., 2001). 
Specifically, data entry and coding can be accomplished with a substantial reduction in labor, expense, 
missing data, and data entry errors compared with traditional paper and pencil daily diary methodology 
(Bauer et al., 2004; Schillewaert & Meulemeester, 2005). Although research indicates large disparities in 
Internet use remain between minority and non-minority groups, minorities are increasingly using the 
Internet (e.g. Fogel, Albert, Schnabel, Ditkoff, & Neugut, 2003; Gant, Turner-Lee, Li, & Miller, 2010). 
According to a recent report by Gant and colleagues (2010), 79% of non-Hispanic Caucasians, 69% percent 
of African Americans, and 59% of Hispanics currently subscribe to residential high-speed Internet, 
representing a continuing trend of increased minority access to the Internet. When taken together these 
findings indicate electronic/internet-based data collection is a feasible method of collecting bio-psycho-
social data from a diverse group of cancer survivors.  
The Present Study 
The primary aim of the current study was to investigate the relations of perceived stress, 
posttraumatic stress symptoms and posttraumatic growth to three health outcome measures -- distress about 
physical health symptoms, quality of life, and depressive symptoms among cancer survivors.  
The first hypothesis was that posttraumatic stress symptoms and posttraumatic growth would be 
associated with distress about physical health symptoms, quality of life, and depressive symptoms and 
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posttraumatic growth would moderate the relation between posttraumatic stress symptoms and the three 
health outcomes.   
Specifically, I hypothesized that posttraumatic stress symptoms would be associated with more 
distress about physical health symptoms, lower quality of life, and more depressive symptoms (H1a) and 
posttraumatic growth would be associated with less distress about physical health symptoms, higher quality 
of life, and fewer depressive symptoms after controlling for posttraumatic stress symptoms (H1b). 
Additionally, I hypothesized that posttraumatic growth would buffer the relation between posttraumatic 
stress symptoms and the three health outcomes (H1c), such that increasing levels of posttraumatic growth 
and decreasing levels of posttraumatic stress would be associated with better health outcomes and 
decreasing levels of posttraumatic growth and increasing levels of posttraumatic stress would be associated 
with worse health outcomes (see Figure 1).  
The second hypothesis was that perceived stress, posttraumatic stress symptoms and posttraumatic 
growth would be associated with distress about physical health symptoms, quality of life, and depressive 
symptoms and perceived stress would moderate the relation between posttraumatic stress symptoms and the 
three health outcomes.   
Specifically, I hypothesized that perceived stress would be associated with more distress about 
physical health symptoms, lower quality of life, and more depressive symptoms (H2a) and perceived stress 
would remain associated with the three health outcomes after controlling for posttraumatic stress symptoms 
and posttraumatic growth (H2b). Additionally, I hypothesized that perceived stress would exacerbate the 
relation between posttraumatic stress symptoms and the three health outcomes (H1c), such that increasing 
levels of perceived stress and posttraumatic stress would be associated with worse health outcomes and 
decreasing levels of perceived stress and posttraumatic stress would be associated with better health 
outcomes (see Figure 2). Statistical testing for the primary hypotheses was two-tailed, with a critical alpha 
of .05 and controlled for relevant demographic and medical variables. 
A secondary aim of the current study was to assess and describe factors related to the feasibility, 
acceptance, ease of use, and efficacy of the online data collection system created for this study, and to 
quantify the efficiency of the recruitment strategy used in the study. Specifically, it was hypothesized that 
the participants would find the online data collection system easy to use and they would be able to 
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participate from a convenient location in a reasonable amount of time. It was further hypothesized that the 
measures on the online questionnaire would demonstrate adequate reliability and validity and the online 
data collection system would improve the efficiency of data collection, as well as streamline the 
recruitment, screening, consent, enrollment, data entry and data management processes when compared to 
traditional paper and pencil questionnaires. 
  
METHOD 
Participants 
  Participants in this study were 168 cancer survivors who were at least 21 years of age, English 
speaking, not currently undergoing active treatment, and had regular internet access with an active email 
account.  The University of North Carolina-Chapel Hill Institutional Review Board of the approved the 
study protocol prior to participant recruitment. The sample consisted of individuals who survived a variety 
of cancers: 31% breast (n=52); 16% ovarian (n =27); 14% leukemia (n =22); and 11% lymphoma (n =19).  
Less than 5% of participants were diagnosed with each of the following types of cancer: bladder (n =5); 
colorectal (n =6); endometrial (n =4); lung (n =2); melanoma (n =3); prostate (n =6); sarcoma (n =4); 
testicular (n =3); and thyroid (n =3).  Participants having multiple types of cancer or other types represented 
2.4 %, (n = 4) and 3%, (n = 5) of the sample respectively.  Participants were on average 53 years of age (SD 
= 11.75, range 22-86 years old).  They were well-educated with the majority reporting holding a minimum 
of a 4-year degree and 57.6% (n = 95) reported that their financial status provided them with expendable 
income. Participants were mostly women (83%), Caucasian (90%), non-Hispanic (96%), currently working 
(64%), and married or living with a significant other (77%). Additionally, participants were on average 7.7 
years post-diagnosis (SD = 7.79 years, range 130 days to 35 years) with an average time since treatment of 
5.5 years (SD = 6.73 years, range 1day to 30 years). Most participants underwent surgery (78%), received 
chemotherapy (69%), and/or radiation therapy (46%), with 30 participants receiving hormone therapy and 
four participants receiving gene therapy. 
Procedure 
Participants were recruited using the University of North Carolina at Chapel Hill’s informational email 
system; email list serves (e.g.  The Association of Online Cancer Resources); social networking sites (e.g.  
Facebook, MySpace, Twitter, NING, and LinkedIN); and by word of mouth. For the initial phase of 
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recruitment, a bulk email was sent to approximately 10,000 faculty/staff and 25,000 students of the 
University of North Carolina – Chapel Hill. In many cases, recipients forwarded these emails to family 
members, friends and colleagues. Some participants completed the questionnaire from as far away as 
Mexico, British Columbia, and the UK. The total number of potential participants to which the initial 
recruitment email was forwarded is unknown.  
Potential participants were directed to a website that briefly described the study and ascertained 
interest in participation. Potential participants interested in the study completed an online form that 
requested their email address, a preferred password for use in the study, and information to be used in the 
screening process. Potential participants were informed that a researcher would contact them to either 
enroll them in the study or explain why they did not meet inclusion criteria. Regardless of eligibility or 
participation status, all potential participants were provided with an email address through which to contact 
study personnel if they had any questions, comments, or concerns. 
Participants who did not meet inclusion criteria received an email thanking them for their interest in 
the study, informing them that they were ineligible, and explaining the specific inclusion criteria that they 
did not meet.  Participant who met inclusion criteria, were sent an email with an embedded link to the 
online consent form and questionnaire. Eligible participants who did not complete the online questionnaire 
within 21 days were sent a second email reminding them of their eligibility to participate in the study and 
providing them with a link to the online consent form and questionnaire. Participants were considered 
enrolled in the study following consent to participate. Additionally participants received the following 
warning: "Although we will be asking you about your physical health symptoms for the purpose of this 
research study we are not in contact with your doctor. Thus, if you have any health concerns during the 
course of this study you should discuss them with a physician."   
After recruitment, screening, consent, and enrollment, participants completed an online questionnaire 
designed to assess posttraumatic stress symptoms, posttraumatic growth, distress about physical health 
symptoms, quality of life, depressive symptoms, perceived stress, posttraumatic cognitions, rumination, and 
personal growth initiative. Additionally, the questionnaire collected information on demographics (gender, 
age, race, marital status, financial status, education, and history of treatment for psychiatric disorder), 
medical status (type of cancer, time since diagnosis, time since treatment, and type of treatment 
22 
 
undergone), and feasibility and acceptance of the online questionnaire. Additional measures, which were 
not included in the current study, were administered using the online questionnaire. Following completion 
of the online questionnaire, participants were offered a $10 Amazon.com gift certificate as compensation 
for participation and were given the opportunity to donate their compensation back to the study. 
Measures 
Predictor Measures to Test Primary Hypotheses 
Posttraumatic stress symptoms. PTSD symptoms were assessed using the PTSD Checklist - Civilian 
Version (PCL-C; Weathers, Huska, & Keane, 1991).  The PCL-C is a 17-item questionnaire that 
corresponds directly to the DSM criteria for PTSD.  Items on the PCL-C are rated on a four-point Likert-
type scale with responses ranging from "Not at all" to "Extremely." The PCL-C has three subscales 
assessing symptoms from the three DSM-IV symptom clusters, namely re-experiencing, avoidance, and 
increased arousal.  Examples of items on each of the three sub-scales include Re-experiencing symptoms 
"Repeated, disturbing memories, thoughts, or images of a stressful experience?" and "Suddenly acting or 
feeling as if a stressful experience were happening again as if you were reliving it?"; Avoidance symptoms 
"Avoiding thinking about or talking about a stressful experience or avoiding having feelings related to it?" 
and "Feeling emotionally numb or being unable to have loving feelings for those close to you?"; and 
Increased Arousal "Having physical reactions (e.g., heart pounding, trouble breathing, sweating) when 
something reminded you of a stressful experience?" and " Feeling jumpy or easily startled?" 
The PCL-C has demonstrated internal reliability with an internal consistency alpha of .93 in the 
current study and adequate test-retest reliability over a 6 week period coefficient = .74 (from pilot testing). 
The PCL-C has been used in research with cancer patients and survivors (Abercrombie et al., 2004; 
Andrykowski, Cordova, Studts, & Miller, 1998; Cordova et al., 1995; Cordova, Studts, Hann, Jacobsen, & 
Andrykowski, 2000; Jacobsen et al., 2002; Morrill et al., 2008; Smith, Redd, DuHamel, Vickberg, & 
Ricketts, 1999).  
Posttraumatic growth. The 21-item Post Traumatic Growth Inventory (PTGI; Tedeschi & Calhoun, 
1996) was used to assess posttraumatic growth. Participants are asked to "indicate for each item the degree 
to which this change occurred in your life as a result of your cancer experience" using a six-point Likert-
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type scale with responses ranging from "not at all" to "a very great degree." The PTGI has five subscales: 
"Relating to Others"; "New Possibilities"; "Personal Strength"; "Spiritual Change"; and "Appreciation of 
Life." Examples of items on each of the five subscales include Relating to Others: "I put more effort into 
my relationships"; New Possibilities: "New opportunities are available which wouldn't have been 
otherwise"; Personal Strength: "I have a greater feeling of self-reliance"; Spiritual Change: "I have a better 
understanding of spiritual matters"; Appreciation of Life: "I changed my priorities about what is important 
in life." 
The PTGI demonstrated adequate internal validity with an internal consistency alpha of .94 in the 
current study and  adequate test-retest reliability has been demonstrated over a two-month period 
coefficient =.70 in previous research (Tedeschi & Calhoun, 1996).  Researchers have used this scale to 
assess posttraumatic growth, positive psychosocial outcomes, and benefit finding among cancer survivors 
(Cordova et al., 2001a; Ho et al., 2004; Morrill et al., 2008). 
Perceived stress was assessed using an electronic visual analogue scale (E-VAS) based upon the 
approach used by Stone and colleagues (Stone, Broderick, Porter, & Kaell, 1997; Stone & Neale, 1982, 
1984). The paper and pencil measure used by Porter and colleagues (2000) was converted into an electronic 
format. Specifically, participants were asked to describe, “What stressful situations have you been dealing 
with over the past two weeks,” to identify the most stressful situation, and to select one of five categories 
which best described this situation: work; marital/romantic relationships; other relationships such as family 
or friends; cancer related; or other.  Finally, participants were asked to rate the perceived level of overall 
stress for the preceding two weeks using an electronic visual analogue scale (E-VAS) stress measure. The 
E-VAS was anchored at “not at all stressful” and “as stressful as I can imagine.” The paper and pencil 
version of this method to assess perceived stress has demonstrated adequate reliability and validity (Gil et 
al., 2003).  
Health Outcome Measures  
Distress from physical health symptoms was assessed using a modified version of the Cohen-
Hoberman Inventory of Physical Symptoms (CHIPS; S. Cohen & Hoberman, 1983). The CHIPS is a 33-
item self-report measure in which respondents are asked to rate how much a particular physical symptom 
(e.g., cold, cough, heart pounding, nausea, sleep problems) distressed them on a five-point scale anchored 
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at “not at all” and “extremely.” In addition to assessing the degree to which participants were bothered by a 
particular symptom participants were asked to indicate if they experienced each symptom during the 
preceding two weeks. The CHIPS demonstrated adequate internal reliability with Cronbach's alpha = .90 in 
the current study.  
In addition, the physical symptoms subscale of the Rotterdam Symptom Checklist (RSCL-PS; de Haes, 
van Knippenberg, & Neijt, 1990) was also used to assess distress about physical symptoms. The RSCL-PS 
is an inventory of physical symptoms designed to assess physical symptoms in cancer patients and 
survivors, and has been used extensively in research with cancer patients and survivors (e.g. de Haes & 
Olschewski, 1998; Eiser, Havermans, Craft, & Kernahan, 1997; Hardy, Edmonds, Turner, Rees, & A'Hern, 
1999). The RSCL-PS demonstrated adequate internal reliability with Cronbach's alpha = .79 in the current 
study. 
Depressive symptoms. Symptoms of depression were assessed using the 20-item Center for 
Epidemiological Studies-Depression Measure (CES-D) (Radloff, 1977). The CES-D demonstrated 
adequate internal consistency with a coefficient alpha of .94 in the current study. Test re-test reliability has 
been established with both cancer patients (r = 0.51, p < 0.001) and healthy controls (r = 0.57, p < 0.001) 
(Hann, Winter, & Jacobsen, 1999). The CES-D is a widely used measure of depressive symptoms in 
relevant studies (Fredrickson, Tugade, Waugh, & Larkin, 2003; Grant, Gil, Floyd, & Abrams, 2000; 
Morrill et al., 2008; Ostir, Markides, Peek, & Goodwin, 2001; Wison et al., 1999). 
Quality of life. Quality of life was measured using the 28-item Functional Assessment of Cancer 
Therapy Scale (FACT-G) (Cella et al., 1993). Each item is rated on a 5-point scale ranging from “not at all” 
to “very much” with regard to how true each item has been during the past 7 days. The FACT-G 
demonstrated adequate internal validity with an internal consistency alpha of .92 in the current study. The 
FACT-G total scale has demonstrated adequate test-retest reliability (r = .92, p < .01) at 3-7 days (Cella et 
al., 1993).  The FACT-G has been used extensively in cancer-related studies (e.g. Brady et al., 1997; 
Dharma-Wardene et al., 2004; Ferrell, Dow, Leigh, Ly, & Gulasekaram, 1995). 
Demographic and Medical Characteristics 
Participants were asked for information about their gender, age, race, marital status, financial status, 
education, and history of treatment for psychiatric disorder. To assess education participants were asked 
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"What is the highest grade in school you completed?" and responses included 10 categories from "Less 
Than High School" to "Advanced Degree (Masters, PhD, MD, JD)." Education was converted into four 
ordinal groupings: "High School Graduate/GED"; "Associates or Technical Degree"; "Bachelors Degree"; 
and "Advanced Degree." Regarding marital status participants were asked "What is your current marital 
status?" Responses included the following choices: "Never married"; "Engaged"; "Married"; "Separated"; 
"Divorced"; "Widowed"; "Living with partner"; and "Other, (please specify)." Marital status was 
dichotomized into two categories, "married or living as married" or "not married or living as married." 
Participants were asked "What is your race?" responses included the following choices: "American Indian 
or Alaska Native"; "Asian"; "Black or African American"; "Native Hawaiian"; "Pacific Islander"; "White 
or Caucasian"; " Bi/Multi Racial"; and "Other, please specify." Additionally participants were asked if they 
consider themselves Hispanic or Latina/Latino. 
To assess financial status participants were asked "Without giving exact dollars, how would you 
describe your household’s financial situation right now?" Responses included "After paying the bills, you 
still have enough money for special things that you want"; "You have enough money to pay the bills, but 
little spare money to buy extra or special things"; "You have money to pay the bills, but only because you 
have cut back on things"; and "You are having difficulty paying the bills, no matter what you do" (Rimer et 
al., 2002). Participants were asked, "Have you ever been treated for a psychiatric disorder?" Regarding 
medical status participants were asked what type of cancer they had been diagnosed with, when their first 
diagnosis was, when their first and last treatments were, and what type(s) of treatments they had undergone 
(i.e. surgery, radiation therapy, chemotherapy, hormone therapy, or gene therapy).  
Variables to Assess Feasibility, Acceptance, and Ease of Use of the Online Questionnaire 
Feasibility and participant acceptance of the online data collection system was assessed using items 
from the assessment tool implemented by the Office of Information and Technology Services at the 
University of North Carolina at Chapel Hill to assess the efficacy of online course evaluations. Specifically 
participants were asked where they completed the questionnaire, how long it took to complete, and how 
difficult it was to complete. To assess difficulty participants were asked how difficult they found the online 
questionnaire to complete; responses were given using an electronic visual analogue scale (E-VAS) 
anchored at “Not difficult at all” and “Extremely difficult.” 
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Measures to Assess Additional Psychosocial Constructs 
Posttraumatic cognitions.  Posttraumatic cognitions were assessed using the 36-item Posttraumatic 
Cognitions Inventory (PTCI; Beck et al., 2004; Foa, Ehlers, Clark, Tolin, & Orsillo, 1999). The PTCI is a 
36-item measure designed to assess posttraumatic cognitions. It consists of three factors: negative 
cognitions about self; negative cognitions about the world; and self-blame. Exemplar items include; 
"People can't be trusted"; "I am inadequate"; "The event happened to me because of the sort of person I 
am"; and "I have permanently changed for the worse." The PTCI demonstrated adequate internal validity 
with an internal consistency alpha of .94 in the current study. Posttraumatic cognitions were also assessed 
with a modified version of the rumination scales used by Calhoun and colleagues (2000).  The items on 
both scales retrospectively assess intrusive and deliberate thoughts, shortly after the trauma and in the 
preceding two weeks, that are common in posttraumatic cognition. The scales include items such as 
“Thoughts about the experience came into my mind and I could not get rid of them" and "I deliberately 
think about the event to try to make sense out of it." The derived “rumination” scale demonstrated adequate 
internal consistency with alpha coefficients of .84. 
Personal growth initiative. The Personal Growth Initiative Scale (PGIS; Robitschek, 1998) was 
incorporated to explore the relation between the constructs of personal and posttraumatic growth. The PGIS 
is a 9-item measure designed to assess personal growth initiative, including items such as "I know how to 
change specific things that I want to change in my life," "If I want to change something in my life, I initiate 
the transition process," and "I know what my unique contribution to the world might be."  The PGIS 
demonstrated adequate internal validity with an internal consistency alpha of .92 in the current study. 
Data Management and Analysis 
 All data were entered by participants into an Adobe Flash™ based user interface and transmitted 
via the internet to a secure server on the UNC network using 128-bit encrypted Secure Socket Layer (SSL) 
protocol and Microsoft Active Server Pages (ASP)™ into a MySQL™ database on a password protected 
web-server located on the UNC-CH internal network. Data were imported into Microsoft Excel for visual 
inspection and de-identification of the data set. The data set was subsequently imported into SPSS for 
further data management and analysis. 
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Inclusion, exclusion, feasibility, and acceptance. Data on inclusion in the study were calculated 
based on the estimated number of participants that were initially contacted, interested in participating, met 
inclusion criteria, and ultimately participated in the study. Information on feasibility and acceptance was 
generated based on the results of the inclusion/exclusion calculations and descriptive statistics from the 
feasibility and acceptance questions.  
Descriptive statistics including mean, standard deviation, and 95% confidence intervals were 
calculated for all demographic (gender, age, race, and education), medical status (type of cancer, time since 
diagnosis and having had surgery, chemotherapy or radiation), primary predictor (posttraumatic growth, 
posttraumatic stress symptoms), health outcome (physical health symptoms, quality of life, and depressive 
symptoms), feasibility/acceptance, and alternative model (perceived stress, rumination, posttraumatic 
cognitions, and personal growth initiative) variables. In order to assess the reliability of the measures on the 
questionnaire, internal reliability analyses (Cronbach's Alpha) were calculated. In order to assess construct 
validity Pearson-product moment correlations were calculated to evaluate the strength, direction, and 
significance of the relations between all primary predictor, primary outcome, and alternative model 
variables. 
Hypothesis testing. Bivariate correlations (Pearson’s r and Spearman’s rho for continuous and ordinal 
variables, respectively) between each demographic, medical, predictor, and health outcome variable were 
calculated to identify potential covariates.  All demographic and medical variables that were correlated at 
the p < .10 level with any of the three health outcome variables were included in subsequent multivariate 
analysis. As recommended by Aiken and West (1991), mean centered scores for all continuous independent 
variables were calculated and used in all subsequent analysis. Additionally, interaction terms (e.g. 
posttraumatic stress symptoms X posttraumatic growth) were calculated by multiplying the previously 
centered variables. Statistical testing was two-tailed, with a critical alpha of .05 and controlled for relevant 
demographic and medical variables. 
To test Hypotheses 1 a series of multivariate analyses of variance (MANOVA) was conducted in 
which scores for each health outcome variable (distress about physical health symptoms, quality of life, and 
depressive symptoms) were regressed on posttraumatic stress symptoms (Hypothesis 1a.); posttraumatic 
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stress symptoms and posttraumatic growth (Hypothesis 1b); and posttraumatic stress symptoms, 
posttraumatic growth and their interaction (Hypothesis 1c).  
To test Hypotheses 2, a series of MANOVA was conducted in which scores for the three health 
outcome variables were regressed on perceived stress (Hypothesis 2a.); perceived stress, posttraumatic 
stress symptoms and posttraumatic growth (Hypothesis 2b.); and perceived stress, posttraumatic stress 
symptoms, posttraumatic growth and the interaction of perceived stress and posttraumatic stress symptoms 
(Hypothesis 2c).  
  
RESULTS 
The results section begins with a summary of the data pertaining to recruitment, inclusion, eligibility, 
participation, feasibility and acceptance of the online data collection system. Second. Second, simple 
descriptive statistics and the results of reliability and validity testing are presented. Third, detailed results of 
testing the specific hypotheses, exploring the relations between posttraumatic stress, perceived stress and 
posttraumatic growth and distress about physical health symptoms, quality of life and depression are given. 
Fourth, the results of post-hoc analyses, exploring the relative effects of rumination, posttraumatic 
cognitions, personal growth initiative, and having a history of treatment for a psychiatric disorder on the 
three health outcome variables are presented. 
Inclusion, Exclusion, Missing Data, Feasibility, and Acceptance 
Of the 257 potential participants that voluntarily responded to the call for participants, 20 were 
found to be ineligible based on inclusion criteria (17 indicated they were undergoing active treatment, 2 
indicated they were not at least 21 years old, and 1 indicated they had not been diagnosed with cancer). Of 
the remaining 237 eligible potential participants, 29% (n = 69) decided not to enroll in the study and the 
remaining 71% of potential participants (n = 168) were enrolled in the study.  Data from one participant 
who enrolled but did not complete several key components of the questionnaire were excluded from further 
analysis. Two participants' data were excluded from further analysis due to scores on one or more of the 
outcome measures that were considered to be extreme outliers (i.e. more than 3.5 times the inter-quartile 
range above or below the median).  Hence, the results below represent findings based on 165 participants. 
The entire process from recruitment through data entry for 165 participants in the current study occurred in 
the 106 days between 09/15/2010 and 01/01/2011.  Of a possible 75,405 data points, less than .01% (n =73) 
were missing and subsequently replaced with the series mean. On average, participants took 55 minutes to 
complete the online questionnaire (SD = 22.15 minutes, range 26 - 108 minutes). Overall, participants rated 
participation as relatively easy with a mean score on the E-VAS difficulty item of 18 out of a possible 100 
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(range 0 - 83). Most participants completed the questionnaire at home (69.7%) or work (25.5%). 
Additionally, of the original 168 participants in the study, 67 (39.9%) opted to donate their $10 
Amazon.com gift card back to the study. These results indicate that participants readily accepted the study 
modality, did not have significant difficulty completing the questionnaire, and many were willing to 
participate in the study without compensation. Additionally, the online data collection system was 
demonstrated to be a well accepted, user friendly, and efficient tool for collecting bio-psychosocial data 
from cancer survivors. 
Descriptive Statistics  
Means, standard deviations, and 95% confidence intervals for all psychosocial variables are 
depicted in Table 1. Of particular interest to the hypotheses of the current study, participants reported 
higher levels of posttraumatic stress symptoms with mean PCL-C scores of 32 (SD = 12.1, 95% CI = 30.4 - 
34.1) when compared to breast cancer patients in my previous research (mean = 24, SD = 7.6, 95% CI = 
22.9 - 25.3) (Morrill et al., 2008).  Eighteen participants (10.9%) met or exceeded the recommended cutoff 
score of 50 on the PCL-C, indicating they would likely meet DSM-IV criteria for PTSD (Weathers et al., 
1991). Participants had relatively lower levels of posttraumatic growth with mean PTGI scores of 65 (SD = 
21.0, 95% CI = 61.9 – 68.3) when compared with breast cancer survivors in my previous research (mean 
73, SD = 21.0) (Morrill et al., 2008).  
On visual inspection of the raw data from the modified Cohen Hoberman Inventory of Physical 
Symptoms (CHIPS), a response pattern was observed whereby participants responded only for symptoms 
that they indicated they had experienced during the preceding two weeks, resulting in 302 missing data 
points. Due to the potential for spurious findings from this response pattern, and the high correlation of r = 
.838, p < .01 between the CHIPS and the physical symptoms subscale of the Rotterdam Symptom Checklist 
RSCL-PS (the other measure of distress about physical health symptoms), the CHIPS was dropped from 
the study.  
Participants' average level of distress from physical symptoms as measured by the RSCL-PS 
(mean = 30, SD = 6.5, 95% CI = 29.00 - 31.02) was similar to previous research with a comparably 
heterogeneous sample of cancer survivors (mean = 29, SD = 7.1) (de Haes et al., 1990). Participants’ 
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quality of life scores (mean = 82, SD = 17.6, 95% CI = 80.2 -85.6) were nearly identical to those of a group 
of 466 mixed cancer patients in the validation study for the FACT-G (mean = 82, SD = 15.9) (Cella et al., 
1993). Levels of depressive symptoms as measured by the CES-D (mean = 13, SD = 11.6, 95% CI = 11.0 - 
14.5) were relatively higher than breast cancer patients (mean = 8, SD = 7.7) in previous research (Morrill 
et al., 2008) and relatively higher than healthy controls (mean = 8, SD = 7.5) reported by Hann and 
colleagues (1999). Using the traditional cutoff score of 16, a total of 46 participants (27.9 %) in the current 
study reported clinically significant depressive symptoms (Radloff, 1977).  
Participants reported a similar level of perceived stress on the E-VAS stress item (mean = 27, SD 
= 22.36, 95% CI = 23.7 - 30.7) when compared with my previous research with a similarly heterogeneous 
sample of cancer survivors (mean = 32.52, SD = 16.05).  Participants reported that their biggest stressors 
were related to work 32.1% (n=53); cancer 24.8% (n=41); romantic/marital 6.1% (n=10); and other 33.3% 
(n=55). Additionally, 39 participants (23.6%) reported having received treatment for a psychiatric disorder. 
Finally, 17 of the 18 participants with PCL-C scores greater than or equal to 50 (indicating a likelihood that 
they would currently meet DSM-IV criteria for PTSD) also reported clinically significant levels of 
depressive symptoms, indicating substantial co-morbidity between depressive and posttraumatic stress 
symptoms among the participants in the current study.  
Reliability and Validity  
As shown in Table 2, posttraumatic stress symptom scores were positively associated with perceived 
stress, posttraumatic cognitions, ruminations, distress about physical health symptoms and depressive 
symptoms, and negatively associated with personal growth initiative and quality of life. Posttraumatic 
growth was positively associated with personal growth initiative and quality of life and negatively 
associated with posttraumatic cognitions and depressive symptoms. Regarding associations among the 
outcome measures, distress about physical symptoms negatively associated with quality of life and 
positively associated with depressive symptoms. Quality of life was negatively associated with distress 
about physical symptoms and depressive symptoms. Depressive symptoms were positively associated with 
distress about physical symptoms and negatively associated with quality of life.  
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Although these results suggest a great deal of inter-variable correlation, they represent adequate 
associations between measures of similar constructs with relatively larger correlations between more 
similar constructs, all of which are in the expected direction indicating acceptable convergent and 
discriminate validity. As shown in Table 3, results of analysis of internal reliability indicate similar levels 
of internal validity for all study variables when compared with paper and pencil versions of the same 
measures from previous research (Beck et al., 2004; Cella et al., 1993; Foa et al., 1999; Hann et al., 1999; 
Morrill et al., 2008; Radloff, 1977; Robitschek, 1998; Tedeschi & Calhoun, 1996). As this was a cross- 
sectional design study, no data on test retest reliability are available for this sample. 
Preliminary Analyses 
With regard to normality, preliminary analyses indicated the need for transformation of the quality of 
life and depressive symptoms variables.  However, no notable differences appeared in results using the 
transformed variables versus non-transformed variables, and thus the results of analyses using the non-
transformed variables are reported.  
In order to determine whether any of the demographic or medical variables were associated with any of 
the outcome or primary predictor variables, bivariate correlations (Pearson’s r and Spearman’s rho for 
continuous and ordinal variables, respectively) were calculated.  As depicted in Table 4, age, gender, 
education, financial status, time since diagnosis, and time since treatment were associated with one or more 
of the outcome measures at the p < .10 level. Due to the near perfect correlation between time since 
diagnosis and time since treatment (r = .97, p < .01) time since treatment was dropped from further 
analysis.  
To evaluate the significance of the association between distress about physical symptoms, quality of 
life and depressive symptoms and the demographic and medical variables, MANOVA was conducted 
regressing the three health outcome variables on age, gender, education level, marital status, financial 
status, and time since diagnosis. Specifically, participants who were older reported lower levels of 
depressive symptoms; women reported higher levels of distress about physical health symptoms; 
participants who were married or living as married reported better quality of life and lower levels of 
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depressive symptoms; and participants with greater financial means reported less distress about physical 
health symptoms, better quality of life, and lower levels of depressive symptoms. 
Interestingly, participants who were further out from diagnosis reported poorer quality of life. A 
graphical representation of the data (scatterplot) suggested that this counter-intuitive finding was a result of 
three participants who were more than 25 years post-diagnosis and reported very low levels of quality of 
life. Results of a bivariate correlation between time since diagnosis and quality of life while excluding these 
participants statistically confirmed this observation. Consequently, all subsequent analyses were conducted 
with and without the data from these three potentially problematic participants. There were no substantial 
differences between the two sets of results. As such there was no statistical justification for excluding the 
participants, as they were not extreme outliers regarding time since diagnosis or quality of life. Moreover, 
the three participants represent an important subset of the cancer survivors (i.e. long term survivors with 
poor quality of life). Therefore, the results of analysis including these three participants are reported below. 
As presented in Table 5, results indicate that age, gender, time since diagnosis, marital status and 
financial status remained associated with one or more of the health outcome variables at the p < .10 level 
following the initial regression. The entire model accounted for 13%, 19%, and 21% of the variance in 
distress about physical health symptoms, quality of life, and depressive symptoms, respectively. All 
subsequent statistical testing was two-tailed, with a critical alpha of .05 and controlled for relevant 
demographic and medical variables.  
Hypothesis 1 Posttraumatic Stress, Posttraumatic Growth, and Health   
As presented in Table 6, results of MANOVA for Hypothesis 1 indicate that posttraumatic stress 
symptom scores were associated with distress about physical symptoms, quality of life, and depressive 
symptoms (H1a) and posttraumatic growth was associated with quality of life and depressive symptoms 
while controlling for posttraumatic stress symptoms (H1b). This model accounted for 43%, 58% and 67% 
of the variance in distress about physical symptoms, quality of life, and depressive symptoms, respectively. 
Posttraumatic growth accounted for 3% and 2% of the variance in quality of life and depressive symptoms 
over and above posttraumatic stress symptoms. However, the interaction between posttraumatic stress 
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symptoms and posttraumatic growth was not significantly associated with any of the three health outcomes 
at the p < .05 level (H1c). 
Hypothesis 2 Perceived Stress, Posttraumatic Stress, Posttraumatic Growth, and Health  
As presented in Table 7 results of MANOVA indicate that perceived stress was associated with the 
three health outcomes (H2a). However, after controlling for posttraumatic stress symptoms and 
posttraumatic growth, perceived stress remained associated with depressive symptoms only (H2b). This 
model accounted for 44%, 56% and 68% of the variance in distress about physical symptoms, quality of 
life, and depressive symptoms, respectively. Posttraumatic growth accounted for 3% and 2% of the 
variance in quality of life and depressive symptoms over and above perceived stress and posttraumatic 
stress symptoms. However, the interaction between perceived stress and posttraumatic stress symptoms 
was not significantly associated with any of the three health outcomes at the p < .05 level (H2c). 
When taken together the results for the main hypotheses indicate that posttraumatic stress symptoms 
were associated with worse health outcomes; posttraumatic growth was associated with higher levels of 
quality of life and lower levels of depressive symptoms, and perceived stress was associated with higher 
levels of depressive symptoms. Additionally, neither the interaction of posttraumatic growth and 
posttraumatic stress symptoms nor the interaction of perceived stress and posttraumatic stress symptoms 
were associated with any of the health outcomes. These results indicate that PTSD symptoms are of 
primary importance when assessing bio-psychosocial health among cancer survivors. 
Post Hoc Analyses 
Although the evaluation of the effect of rumination, posttraumatic cognitions, personal growth 
initiative, and having a history of treatment for a psychiatric disorder on the three health outcome variables 
was not the original aim of the study, as described in detail below, there was sufficient theoretical and 
empirical rationale for examining the effects of these psychosocial constructs. Thus, the current study 
examined six alternative models exploring the relations between these potentially salient constructs, the 
two primary predictor variables (posttraumatic stress symptoms and posttraumatic growth) and the three 
health outcomes (distress about physical health symptoms, quality of life, and depressive symptoms).  For 
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ease of comparison between models, post hoc analyses were conducted using a similar analytic strategy to 
that described for Hypothesis 1.  As such, statistical testing for the post hoc analyses was two-tailed, with a 
critical alpha of .05 and controlled for relevant demographic and medical variables.  
Omnibus model. The initial post-hoc analysis (model three) was conducted using MANOVA.  
Specifically, scores for the three health outcome variables were regressed on posttraumatic stress 
symptoms, posttraumatic growth, perceived stress, rumination, posttraumatic cognitions, personal growth 
initiative, and a history of treatment for a psychiatric disorder while controlling for the relevant 
demographic and medical variables. As presented in Table 8, results indicate that posttraumatic stress 
symptoms scores were significantly associated with distress about physical symptoms, quality of life, and 
depressive symptoms.  Perceived stress was associated with depressive symptoms.  Posttraumatic cognition 
scores were associated with quality of life and depressive symptoms. Personal growth initiative was 
associated with quality of life and depressive symptoms. Posttraumatic growth, having a history of 
treatment for a psychiatric disorder, and rumination were not significantly associated with any of the three 
health outcomes at the p < .05 level. The entire model accounted for 45%, 66%, and 72% of the variance in 
distress about physical health symptoms, quality of life, and depressive symptoms, respectively.  
Results of analysis testing the omnibus model indicate that, even while controlling for all other study 
variables, higher levels of posttraumatic stress symptoms were associated with poorer health outcomes; 
higher levels of posttraumatic cognitions were associated with worse quality of life and more depressive 
symptoms. Higher levels of personal growth initiative were associated with better quality of life and fewer 
depressive symptoms, and more perceived stress was associated with higher levels of depressive symptoms. 
Additionally, results of the omnibus test highlights the importance of assessing posttraumatic stress from 
both symptoms- and cognitions based perspectives as each have a significant effect on bio-psychosocial 
health in cancer survivors.  
To explore the effect of each individual variable of interest on the three health outcomes in more detail 
than was possible in the omnibus model, five additional models (models 3-7) were tested using MANOVA. 
Specifically, the three health outcome variables were regressed on each of the variables of interest (i.e. 
ruminations, posttraumatic cognitions, personal growth initiative, or having a history of treatment for a 
psychiatric disorder) in the initial step.  The second step in the analytic procedure included posttraumatic 
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stress symptoms and posttraumatic growth in the model. If the particular model being tested included an 
interaction term, it was added and evaluated in step three. The final post-hoc model (model eight) evaluated 
the significance of the association between depressive symptoms and distress about physical symptoms and 
quality of life using the previously described analytic procedure.  
Models 4 and 5: Rumination and posttraumatic cognitions. Researchers have emphasized the 
importance of rumination and posttraumatic cognitions in the development and maintenance of 
posttraumatic stress symptoms (Beck et al., 2004; Calhoun et al., 2000; Foa et al., 1999).  Several items on 
the measures used in the current study to assess ruminations and posttraumatic cognitions could be used to 
assess factors on both the re-experiencing and avoidance symptom clusters as defined by the Diagnostic 
and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV; American Psychiatric Association, 
1994). The potential theoretical overlap between the constructs of posttraumatic stress symptoms, 
rumination, and posttraumatic cognitions is bolstered by the results of preliminary data analyses in the 
current study as evidenced by the moderate to high correlations between posttraumatic stress symptoms and 
rumination (r = .54, p <.01) and posttraumatic cognitions (r = .73, p <.01). 
As previously outlined, both of these relevant constructs play an important role in the theoretical 
framework of posttraumatic growth.  Specifically the transformation of automatic, intrusive, negative 
ruminations, posttraumatic cognitions, and intrusive thoughts into positive, growth oriented, narrative-
developing intentional thoughts is central to Tedeschi and Calhoun's (2004) model of the psychosocial 
process by which posttraumatic growth develops. Thus, models three and four evaluated the relative effect 
of rumination, posttraumatic cognitions, and the interactions of posttraumatic growth with rumination, and 
posttraumatic cognitions on the three health outcomes 
Model 4 examined the relative effect of rumination on the three health outcomes. As presented in 
Table 9, results indicate that rumination was significantly associated with distress about physical 
symptoms, quality of life and depressive symptoms. The entire model accounted for 26%, 32%, and 30% of 
the variance in distress about physical health symptoms, quality of life, and depressive symptoms, 
respectively. Rumination accounted for 13%, 14%, and 8% of the variance in distress about physical health 
symptoms, quality of life, and depressive symptoms over and above relevant demographic and medical 
variables. However, after including posttraumatic stress symptoms and posttraumatic growth in the model, 
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results indicate that rumination did not remain significantly associated with any of the health outcomes 
measures at the p < .05 level. The entire model accounted for 44%, 59%, and 67% of the variance in 
distress about physical health symptoms, quality of life, and depressive symptoms, respectively. 
Posttraumatic growth accounted for 3% and 2% of the variance in quality of life and depressive symptoms 
over and above rumination and posttraumatic stress symptoms. Additionally the interaction of rumination 
and posttraumatic growth was not significantly associated at the p < .05 level with any of the three 
outcomes.  
Model 5 examined the relative effect of posttraumatic cognitions on the three health outcomes. As 
presented in Table 10, results indicate that posttraumatic cognitions were significantly associated with 
distress about physical symptoms, quality of life, and depressive symptoms.  The entire model accounted 
for 35%, 55%, and 58% of the variance in distress about physical health symptoms, quality of life, and 
depressive symptoms, respectively. Posttraumatic cognitions, as measured by the PTCI, accounted for 22%, 
36%, and 36% of the variance in distress about physical health symptoms, quality of life, and depressive 
symptoms over and above relevant demographic and medical variables. 
After including posttraumatic stress symptom and posttraumatic growth in the model, results indicate 
that posttraumatic cognition scores remained associated with all three health outcomes.  The entire model 
accounted for 45%, 64%, and 70% of the variance in distress about physical health symptoms, quality of 
life, and depressive symptoms, respectively. Posttraumatic growth accounted for 2% and 1% of the 
variance in quality of life and depressive symptoms over and above posttraumatic cognitions and 
posttraumatic stress symptoms. However, the interaction of posttraumatic cognition scores and 
posttraumatic growth was not significantly associated with any of the three outcomes at the p < .05 level.  
When taken together, the results of analyses for rumination and posttraumatic cognitions indicate that 
higher levels of posttraumatic cognitions were associated with worse health outcomes; however, rumination 
was not significantly associated with any of the health outcomes while controlling for posttraumatic stress 
symptoms and posttraumatic growth. Furthermore, the interaction of posttraumatic growth with 
posttraumatic cognitions and the interaction of posttraumatic growth with rumination were not significantly 
associated with any of the three health outcomes at the p < .05 level.  
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Model 6: Personal growth initiative. As previously discussed, personal growth has been 
described as an important process that produces positive personal change and development. 
Developmental, environmental, and intentional events and processes can act as a catalyst for continued 
personal growth across the lifespan (Robitschek, 1998). Cancer diagnosis, treatment, and survivorship 
could be seen as an example of a traumatic environmental experience that has the potential to foster 
ongoing personal growth. When personal growth is stimulated by a traumatic environmental event or 
process such as the cancer experience, it is often referred to as posttraumatic growth or benefit finding 
(Widows et al., 2005). In their discussion of trauma and transformation Tedeschi and Calhoun (1995) 
indicate that this type of personal development can be triggered by traumatic experiences such as cancer 
diagnosis, treatment, and survivorship.  In addition to the theoretical overlap between the constructs of 
personal and posttraumatic growth, results of preliminary analysis indicate that there are moderate to high 
correlations between personal growth and posttraumatic growth and all three health outcome variables are 
significant at the p < .01 level. Thus, model 6 evaluated the relative effect of personal growth initiative, 
posttraumatic stress symptoms, posttraumatic growth and the interaction of personal growth initiative with 
posttraumatic stress symptoms on the three health outcomes. 
As presented in Table 11, results indicate that personal growth initiative was associated with distress 
about physical symptoms, quality of life, and depressive symptoms.  The entire model accounted for 24%, 
46%, and 47% of the variance in distress about physical health symptoms, quality of life, and depressive 
symptoms, respectively. Personal growth initiative, as measured by the PGIS accounted for 11%, 28%, and 
26% of the variance in distress about physical health symptoms, quality of life, and depressive symptoms 
over and above relevant demographic and medical variables. 
After including posttraumatic stress symptom and posttraumatic growth in the model, results indicate 
that personal growth initiative remained associated with quality of life and depressive symptoms.  
However, posttraumatic growth was not significantly associated with any of the health outcomes at the p < 
.05 level.  The entire model accounted for 44%, 64%, and 70% of the variance in distress about physical 
health symptoms, quality of life, and depressive symptoms, respectively.  Additionally, the association 
between the interaction of personal growth initiative and posttraumatic stress symptoms was associated 
39 
 
with quality of life at the p < .05 level. The entire model accounted for 44%, 64%, and 70% of the variance 
in distress about physical health symptoms, quality of life, and depressive symptoms, respectively.  
To explicate the significant interaction, multiple linear regression analysis was conducted in which 
quality of life was regressed on personal growth initiative, posttraumatic stress symptoms, and the 
interaction of personal growth initiative and posttraumatic stress symptoms while controlling for 
demographic and medical variables that were associated with quality of life at the p < .10 level. The 
interaction effect was explicated using Aiken and West’s (1991) method for probing interactions among 
continuous variables.  Specifically the results of the aforementioned analysis were used to plot simple 
slopes with points at one standard deviation above and below the mean for personal growth initiative, and 
from the lowest level to the highest level in the sample for posttraumatic stress symptoms. The graph 
depicted in Figure 3 indicates that increasing levels of personal growth initiative and decreasing levels of 
posttraumatic stress were associated with better health outcomes, and decreasing levels of personal growth 
initiative, and increasing levels of posttraumatic stress were associated with worse health outcomes. 
Results of these analyses indicate that participants who reported more personal growth initiative 
experienced better quality of life and fewer depressive symptoms.  Posttraumatic growth was not 
significantly associated with any of the three health outcomes while controlling for posttraumatic stress and 
personal growth initiative, indicating potential mediation of the relation between posttraumatic growth and 
quality of life and depressive symptoms by personal growth initiative. Additionally, personal growth 
initiative appeared to buffer the relation between posttraumatic stress symptoms and quality of life.  
Models 7 and 8: Previous psychiatric diagnosis and depressive symptoms. Research has indicated 
that as many as 39% of cancer patients meet criteria for a psychiatric disorder (Derogatis et al., 1983; 
Harrison, Maguire, Ibbotson, MacLeod, & Hopwood, 1994; Mehnert & Koch, 2007).  According to 
Derogatis and colleagues (1983) the vast majority of patients who meet criteria for a psychiatric disorder 
suffered from depression, anxiety, or both. As discussed by Clark and Watson (1991) there is considerable 
overlap between the symptoms of anxiety disorders such as PTSD and depression. In fact, research in both 
humans and animals have demonstrated physiological underpinnings that explain the overlap in 
symptomatology of anxiety and mood disorders such as PTSD and depression (Fuchs et al., 2004; 
Vermetten et al., 2003). Given the substantial overlap in symptoms of depression and PTSD, the elevated 
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levels of depressive and posttraumatic stress symptoms, and high co-morbidity reported by participants in 
the current study, it is important to evaluate the extent to which current depression or a history of treatment 
for a psychiatric disorder may have a role in explaining psychosocial health among cancer survivors. Thus, 
models 7 and 8 evaluated the relative effect of having a history of treatment for a psychiatric disorder on 
the three health outcomes and the effect of depressive symptoms on the other two health outcomes, distress 
about physical health symptoms and quality of life, respectively.  
Model 7 examined the relative effect of having a history of treatment for a psychiatric disorder on the 
three health outcomes. As presented in Table 12, results indicate that having a history of treatment for a 
psychiatric disorder was associated with distress about physical symptoms, quality of life, and depressive 
symptoms.  The entire model accounted for 18%, 25%, and 24% of the variance in distress about physical 
health symptoms, quality of life, and depressive symptoms, respectively.  Having a history of treatment for 
a psychiatric disorder accounted for 5%, 6%, and 3% of the variance in distress about physical health 
symptoms, quality of life, and depressive symptoms over and above relevant demographic and medical 
variables. 
After adding posttraumatic stress and posttraumatic growth to the model, results indicate that a history 
of treatment for a psychiatric disorder did not remain significantly associated with any of the three health 
outcomes at the p < .05 level. The entire model accounted for 44%, 59%, and 66% of the variance in 
distress about physical health symptoms, quality of life, and depressive symptoms, respectively. 
Posttraumatic growth accounted for 2% and 1% of the variance in quality of life and depressive symptoms 
over and above having a history of treatment for a psychiatric disorder and posttraumatic stress symptoms. 
Model 8 examined the relative effect of depressive symptoms on distress about physical symptoms and 
quality of life.  As presented in Table 13, results indicate that depressive symptoms were associated with 
distress about physical symptoms and quality of life.  The entire model accounted for 49% and 62% of the 
variance in distress about physical health symptoms and quality of life. Depressive symptoms, as measured 
by the CES-D, accounted for 35% and 44% of the variance in distress about physical health symptoms and 
quality of life over and above relevant demographic and medical variables. 
After adding posttraumatic stress symptoms and posttraumatic growth to the model, results indicate 
that depressive symptoms remained associated with distress about physical symptoms and quality of life. 
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Posttraumatic stress symptoms scores were associated with distress about physical symptoms and quality of 
life, and posttraumatic growth was associated with quality of life.  The entire model accounted for 51% and 
66% of the variance in distress about physical health symptoms and quality of life, respectively. 
Posttraumatic growth, as measured by the PTGI, accounted for less than 1% of the variance in quality of 
life over and above depressive symptoms and posttraumatic stress symptoms. 
When taken together, the results of analyses for a history of treatment for a psychiatric disorder and 
depressive symptoms indicate participants with higher levels of depressive symptoms experienced more 
distress about physical health symptoms and poorer quality of life. However, having a history of treatment 
for a psychiatric disorder did not remain associated with any of the health outcomes while controlling for 
posttraumatic stress symptoms scores and posttraumatic growth. 
Summary of Results 
For ease of comparison between the models tested in the current study, the amount of variance in each 
health outcome accounted for by each predictor and ensuing model for the main hypotheses and post hoc 
analyses are depicted in Table 14 and Table 15, respectively. 
When taken as a whole the previously described results partially support Hypotheses 1. Posttraumatic 
stress symptoms were associated with poorer health outcomes (H1a), posttraumatic growth was associated 
with better quality of life and fewer depressive symptoms (H1b), and these results remained relatively 
unchanged with both posttraumatic stress symptoms and posttraumatic growth in the model (H1c). 
However, the buffering effect of posttraumatic growth on the relation between posttraumatic stress 
symptoms and the three health outcomes was not supported (H1d). Additionally, regarding Hypothesis 2 
perceived stress was associated with poorer health outcomes (H2a), although after controlling for 
posttraumatic stress symptoms and posttraumatic growth, perceived stress remained associated with 
depressive symptoms only (H2b). Furthermore, the exacerbating effect of perceived stress on the relations 
between posttraumatic stress symptoms and the three health outcomes was not supported (H2c). 
The results of post-hoc analyses indicate participants with higher levels of posttraumatic cognitions or 
more depressive symptoms reported more distress about physical health symptoms. Participants with lower 
levels of posttraumatic cognitions and/or higher levels of personal growth initiative reported better quality 
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of life. Participants who experienced lower levels of perceived stress, fewer posttraumatic cognitions, or 
higher levels of personal growth initiative reported less depressive symptoms.  Rumination and having a 
history of treatment for a psychiatric disorder did not account for a significant amount of the variance in 
any of the health outcomes while controlling for posttraumatic stress symptoms and posttraumatic growth.  
Overall, posttraumatic stress symptoms accounted for a significant amount of the variance in all three 
health outcomes across all models while controlling for all predictors. Thus, the results of the current study 
indicate posttraumatic stress is of primary importance when assessing bio-psychosocial health among 
cancer survivors. Although posttraumatic growth accounted for a significant amount of variance in quality 
of life and depressive symptoms in all models except for models controlling for personal growth initiative, 
the unique contribution of posttraumatic growth was relatively small (range R2 = .09% - R2 = 3.1%).  
Results of analyses exploring the effect of posttraumatic growth and personal growth initiative on the 
three health outcomes may indicate potential mediation of the relations between posttraumatic growth and 
quality of life and depressive symptoms by personal growth initiative. Finally, personal growth initiative 
appeared to buffer the relation between PTSD symptoms and quality of life at the p < .05 level.   
Generally, these results highlight potential ramifications of posttraumatic stress, growth and cognitions 
as they relate to distress about physical health symptoms, quality of life and depressive symptoms in cancer 
survivors.  Additionally, these results indicate the importance of assessing posttraumatic stress from both 
symptoms and cognitions based perspectives as each have a significant effect on bio-psychosocial health in 
cancer survivors. Finally, results highlight the potential importance of personal growth and its buffering 
effect on the relation between PTSD symptoms and quality of life and when making inferences about the 
effect of posttraumatic growth on quality of life and depressive symptoms.  
  
DISCUSSION 
The discussion section is organized as follows:  First, I provide an overview of the findings of the 
study regarding the posttraumatic growth and posttraumatic stress as they relate to the conceptual model 
put forth in the introduction;  Second, findings regarding the role of perceived stress,  the feasibility and 
acceptance of the online data collection system, and post-hoc analyses as they relate to previous research 
are presented; third, limitations of the study are discussed; and  fourth, implications of the results of the 
current study as they relate to future research and clinical practice are presented. 
Overview 
Building on cognitive theory and positive psychology this cross-sectional study sought to examine a 
theoretical model of the buffering effect of posttraumatic growth on the relation between posttraumatic 
stress symptoms and health outcomes among cancer survivors. Specifically, I examined four principle 
components of the model: the relation between the experience of cancer diagnosis, treatment, and 
survivorship and posttraumatic stress; the relation between posttraumatic stress and well-being; the relation 
between posttraumatic growth and well-being; and the potentially buffering effect of posttraumatic growth 
on the relation between posttraumatic stress and well-being. 
Cancer and posttraumatic stress.  For many, the cancer experience starts with apprehension and 
ambiguity prior to a screening test, such as mammography or colonoscopy. For others the cancer 
experience begins with a problematic symptom, lump, or other physical manifestation such as a seizure or 
the rapid onset of severe and debilitating pain that might lead to an emergency room visit (American 
Cancer Society, 2010).  Regardless of how a person's cancer experience begins, the most common forms of 
treatment following diagnosis are surgery, irradiation, chemotherapy, and in many cases, some form of 
maintenance therapy to prevent recurrence (National Cancer Institute, 2011a). Cancer patients often 
experience unpleasant side effects from prolonged treatment including nausea, hair loss, fatigue, and 
cognitive deficits (Kangas et al., 2002).   
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In general, the initial phases of diagnosis and active treatment seem to be the most traumatic or life-
altering aspects of the cancer experience. However, many cancer survivors continue to have fatigue, pain, 
swelling, acute illnesses, fears of recurrence, and psychological distress for many years following active 
treatment (Abercrombie et al., 2004; Gil, Mishel et al., 2004; Golden Kreutz et al., 2004; Morrill et al., 
2008; National Cancer Institute, 2007b).   
Although, the prevalence of diagnosable psychiatric disorders in cancer survivors is similar to that 
found in the general population (Mehnert & Koch, 2007), many individuals who survive cancer appear to 
be at risk for significant psychological problems that may persist for years after the conclusion of treatment 
(Gurevich et al., 2004; Kangas et al., 2002). In the current study of cancer survivors, who were up to 35 
years post-diagnosis, as many as 11% of participants likely met criteria for PTSD.  This level of occurrence 
of PTSD symptoms supports the theorized relation between cancer diagnosis, treatment, and survivorship 
and posttraumatic stress and demonstrates a substantial number of cancer survivors may suffer from PTSD 
symptoms which may in turn lead to poorer physical and psychological health outcomes. 
Posttraumatic stress and well-being.  Findings regarding the link between posttraumatic stress 
symptoms and well-being support the theoretical model of the study and extend previous research that has 
reported associations between PTSD symptoms and well-being among cancer patients and survivors 
(Cordova et al., 1995; Morrill et al., 2008; Schwartz & Drotar, 2006).  As predicted the current study found 
a positive association between PTSD symptoms and distress about physical health symptoms and 
depressive symptoms as well as a significant negative association between PTSD symptoms and quality of 
life.  In our previous research we found similar results regarding the prediction of quality of life and 
depressive symptoms in a sample of breast cancer survivors (Morrill et al., 2008), but physical health 
symptoms were not measured. The current findings suggest a link between PTSD symptoms and distress 
about physical health symptoms in cancer survivors in addition to quality of life and depressive symptoms.  
This finding is important since not only are physical health symptoms problematic in their own right, it is 
possible that they may  trigger uncertainty about cancer recurrence, potentially leading to more distress 
(Gil, Mishel et al., 2004).   
Although cancer-related PTSD is not substantially more common among cancer survivors than the 
general population, up to half of cancer patients and survivors may experience posttraumatic stress 
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symptoms as a result of their disease (Gurevich et al., 2004). Thus considering the link between cancer-
related PTSD symptoms well-being and the fact that there are nearly 12 million cancer survivors  in the 
United States, cancer-related posttraumatic stress symptoms have the potential to negatively impact the 
lives of millions of cancer survivors (National Cancer Institute, 2011b). 
Posttraumatic growth and well-being. The current study put forth the hypotheses that in the 
context of the cancer experience, posttraumatic growth may improve important psychological outcomes, 
including distress about physical health symptoms, quality of life, and depression. Results of the current 
study support the conceptual model, and are consistent with previous research that has reported associations 
between posttraumatic growth and quality of life and depressive symptoms (Helgeson et al., 2006; Morrill 
et al., 2008; Stanton et al., 2006). For example, in a meta-analytic review of 87 cross-sectional studies, 
Helgeson and colleagues (2006) found consistent associations between posttraumatic growth and fewer 
depressive symptoms in various samples of cancer patients and survivors. As a result of their 
comprehensive review of the literature on posttraumatic growth, Stanton and colleagues (Stanton et al., 
2006) found mixed results regarding the association between posttraumatic growth and quality of life, with 
some studies finding significant positive associations, other studies finding significant negative 
associations, and most studies reporting no significant findings. Thus, results from the current study bolster 
research reporting a link between posttraumatic growth and depressive symptoms and quality of life and 
highlight the importance of posttraumatic growth regarding psychosocial health among cancer survivors.  
The buffering effect of posttraumatic growth.  Tedeschi and Calhoun (2004) proffered the idea 
that posttraumatic growth may also offer more complex benefits than those previously explored in the 
literature. Based on this supposition, the current study put forth a conceptual model that included a 
theorized buffering effect of posttraumatic growth on the relation between posttraumatic stress and well-
being in cancer survivors. The findings of the current study failed to support this component of the 
theoretical model and were inconsistent with previous research (Morrill et al., 2008; Park et al., 2010). 
Although Park and colleagues did not utilize an omnibus measure of PTSD symptoms, they report a 
buffering effect of posttraumatic growth on the relations between intrusive thoughts and spiritual well-
being, life satisfaction, and negative affect. 
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Some of the differences in results between the current study and our previous research may be 
sample-related. The current study sample which included survivors of any type of cancer was more 
heterogeneous than our previous research focusing on breast cancer survivors (Morrill et al., 2008). 
Specifically, the inclusion of participants with multiple types and stages of cancer diagnoses in the current 
study introduces extraneous variance in the outcome variables due to disease characteristics. This type of 
variance is not present in a sample comprising survivors of a single type of cancer.   
Relative levels of psychopathology among participants may also have led to the disparity in 
results. Participants in the current study reported higher levels of posttraumatic stress symptoms when 
compared to breast cancer patients in our previous research (Morrill et al., 2008).  In the current study, 
10.3% (n = 16) of participants met or exceeded the recommended cutoff score of 50 on the PCL-C, 
indicating they would likely meet DSM-IV criteria for PTSD (American Psychiatric Association, 1994; 
Weathers et al., 1991). Levels of depressive symptoms as measured by the CES-D in the current study were 
relatively higher than breast cancer patients in our previous research (Morrill et al., 2008). Using the 
traditional cutoff score of 16, nearly 30% of participants reported clinically significant depressive 
symptoms (Radloff, 1977). Additionally, 23.6% of participants reported having received treatment for a 
psychiatric disorder whereas our previous research excluded participants with a history of serious 
psychiatric diagnosis (Morrill et al., 2008). Additionally, participants in the current study reported lower 
levels of posttraumatic growth when compared to our previous research (Morrill et al., 2008). Thus, the 
increased presence of potential psychopathology may have mitigated the hypothesized buffering effect of 
posttraumatic growth. Specifically, it is possible that the buffering effect of posttraumatic growth is 
moderated by severity of psychopathology.   
Conceptual summary.  When taken together findings of the current study indicate that many cancer 
survivors experience profound changes between their pre sense of self and world view and their sense of 
self and world view following diagnosis and treatment. This disparity may lead to PTSD symptoms, which 
cancer survivors may experience for years following diagnosis. Additionally, this response to profound 
schema change may lead to increased negative psychological responses (i.e. anxiety, negative affect, 
intrusive thoughts, catastrophic thinking, posttraumatic cognitions, rumination, and intrusive thoughts). 
47 
 
Furthermore, PTSD symptoms may play an important role in quality of life and both physical and 
psychological health among cancer survivors.  
Despite the negative bio-psycho-social outcomes of cancer and cancer related PTSD symptoms many 
cancer survivors experience posttraumatic growth which may include a transformation of their automatic, 
intrusive, and negative ruminations into deliberate, growth oriented, narrative developing ruminations by a 
combination of internal and external self disclosure, positive social support, active coping, cognitive 
reframing, and disengagement from previous goals and incorporation of revised life goals. Additionally 
findings of the current study indicate a link between posttraumatic growth and better quality of life, and 
lower levels of depressive symptoms. 
Although findings of the current study did not support the theorized buffering effect of 
posttraumatic growth, personal growth,  a closely related construct,  did appear to moderate the relation 
between PTSD symptoms and quality of life in beneficial ways. These results indicate that a broader 
conceptualization may be needed to capture the growth that may occur during the cancer experience and 
highlight the importance of assessing personal growth in addition to posttraumatic growth in future 
research attempting to elucidate the potential positive outcomes of inherently negative life experiences. 
Perceived Stress, Posttraumatic Stress Symptoms, Posttraumatic Growth and Health 
The results of the current study indicate that perceived stress accounted for a substantial amount of 
variance in distress about physical health symptoms, quality of life, and depressive symptoms (H2a). 
However, after controlling for posttraumatic stress symptoms and posttraumatic growth, perceived stress 
remained associated with only depressive symptoms (H2b).  The results regarding the main effects of 
perceived stress as it relates to bio-psychosocial health partially support the hypotheses and are generally 
consistent with previous research in cancer survivors and other chronically ill groups (S. Cohen et al., 1993; 
DeLongis et al., 1988; Gil, Carson et al., 2004; Reibel et al., 2001). For example, Cohen and colleagues 
(1993) report significant associations between perceived stress, negative affect and negative health 
outcomes in a sample of healthy participants who were exposed to a common cold virus and monitored for 
the presence of clinical illness. When PTSD symptoms and posttraumatic growth were added to the model, 
perceived stress did not remain associated with physical symptoms and quality of life. This indicates the 
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possibility that PTSD symptoms mediate the association between perceived stress and physical health 
symptoms and quality of life. Furthermore, results did not support the hypothesized exacerbating effect of 
perceived stress on the relations between posttraumatic stress symptoms and the three health outcomes 
(H2c).  
Thus, results of the current study emphasize the importance of PTSD symptoms regarding bio-
psychosocial health among cancer patients and survivors.  Furthermore, because PTSD symptoms may 
confound the relations between perceived stress and well-being, results highlight the necessity of assessing 
PTSD symptoms in research exploring the associations between perceived stress, physical health 
symptoms, and quality of life among cancer survivors.   These findings have important implications 
regarding increased screening for PTSD among cancer patients and survivors.  Ideally screening should 
lead to referral for further diagnostic assessment and treatment of PTSD where clinically appropriate.  
Internet-Based Data Collection 
Over the past decade, researchers have become increasingly interested in use of Internet-based data 
collection methods (Bauer et al., 2004; Bliven et al., 2001; Fergusson et al., 2003; Park et al., 2004; 
Whybrow et al., 2003).  This is partially due to increasing levels of internet access, the inherent ability to 
reach participants where and when it is convenient for them, and the superior efficiency of internet-based 
data collection when compared to face-to-face and paper and pencil methodology.  
For the current study, I designed an easy to use Internet-based data collection system to assess bio-
psychosocial factors among cancer survivors.  The current study extends research on internet-based data 
collection by evaluating bio-psychosocial health in cancer survivors. Consistent with previous research, 
results of this study indicate that participants were comfortable using the online application and did not 
have difficulty completing the questionnaire without additional technical support (Bliven et al., 2001). 
Additionally, the internet-based data collection system used in this study increased the efficiency of data 
collection. Compared to traditional paper and pencil questionnaires that are commonly returned by mail and 
hand-scored with subsequent manual data entry and coding, the online system streamlined the recruitment, 
screening, consent, enrollment, data entry, and data management processes.  Specifically, in the current 
study recruitment, screening, consent, enrollment, data entry and coding were accomplished for 168 
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participants in 108 days with a substantial reduction in labor, expense, and missing data when compared to 
traditional paper and pencil survey methodology.   
The online data collection application took, on average, less than one hour to complete. Most 
participants completed the questionnaire in their home or at work and indicated that they found the online 
questionnaire easy to use. Additionally, nearly 40% of participants opted to donate their gift card back to 
the study. These results indicate that participants readily accepted the study modality, they did not have 
significant difficulty completing the questionnaire, and many were willing to participate in the study 
without compensation. 
As depicted in Table 3 internal reliability of the electronic measures was comparable with that of paper 
and pencil versions of the same measures reported in previous research (Beck et al., 2004; Cella et al., 
1993; Foa et al., 1999; Hann et al., 1999; Morrill et al., 2008; Radloff, 1977; Robitschek, 1998; Tedeschi & 
Calhoun, 1996). These findings extend previous research on internet-based data collection into the area of 
psycho-oncology (Bliven et al., 2001; Cantrell & Lupinacci, 2007; Metzger et al., 2003; Ritter et al., 2004).  
For example, Ritter, and colleagues (2004) reported that among chronically ill participants no 
significant psychometric differences were found in 14 of the 16 self-report psychological and physical 
health related measures completed. Bliven and colleagues (2001) reported that in a sample of cardiology 
outpatients, more than 80% preferred the internet-based collection over the paper and pencil versions, 
nearly 90% were comfortable using the application without additional technical support, and that data 
collected using electronic and paper and pencil versions were consistent. 
Furthermore, the current study extends research on internet-based data collection by evaluating the 
effects of posttraumatic stress symptoms and posttraumatic growth on distress about physical health 
symptoms, quality of life, and depressive symptoms in cancer survivors. Implications for future research 
include the use of the online data collection system designed for this study in conjunction with 
physiological measures or neuropsychological assessment. Clinical implications of the results include the 
use of ongoing online assessment of bio-psychosocial health in conjunction with face-to-face and telehealth 
based clinical services.  
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Despite the advantages, however, issues specific to internet-based data collection arose. For example, 
not all cancer patients and survivors have reliable internet access, limiting samples to those with access, 
thus reducing potential inclusion and therefore generalizability.  
The Role of Demographic and Medical Variables 
Results of the current study indicate that participants who were older reported lower levels of 
depressive symptoms; women reported higher levels of distress about physical health symptoms; and 
participants who were married or living as married reported better quality of life and lower levels of 
depressive symptoms. Additionally, participants with greater financial means reported less distress about 
physical health symptoms, better quality of life, and lower levels of depressive symptoms. Although age, 
gender, and marital status each was associated with one or more health outcomes, financial status was the 
strongest demographic or medical predictor of positive health outcomes among cancer survivors. Thus, it is 
possible that having greater financial resources may be associated with increased access to physical and 
mental healthcare services, more social support, and increased psychosocial resources with which to cope 
with cancer and non-cancer related stressors.  
Post Hoc Analyses 
Omnibus model. The first post-hoc model examined the associations between all of the primary and 
alternative model predictors and the three health outcomes simultaneously to assess their unique 
contribution while controlling for all other study variables. Results indicate that even while controlling for 
all other predictors, PTSD symptoms were associated with poorer health outcomes; posttraumatic 
cognitions were associated with poorer quality of life and higher levels of depressive symptoms; personal 
growth initiative was associated with better quality of life and lower levels of depressive symptoms; and 
perceived stress was associated with higher levels of depressive symptoms.  
Results of the omnibus test highlight the importance of assessing posttraumatic stress from both 
symptoms and cognitions-based perspectives as each are independently associated with well-being in 
cancer survivors.  
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Posttraumatic cognitions. Researchers have emphasized the importance of posttraumatic cognitions 
in the development and maintenance of posttraumatic stress symptoms (Beck et al., 2004; Calhoun et al., 
2000; Foa et al., 1999). For example, Foa and colleagues (1999) reported that the posttraumatic cognitions 
inventory (PTCI) was able to discriminate between traumatized individuals with and without PTSD even 
after controlling for depression and anxiety. Although posttraumatic cognitions and intrusive thoughts are 
similar but distinct constructs, many of the items on the PTCI form the content of common intrusive 
thoughts among cancer survivors. Previous research conducted by Whitaker and colleagues (2009) has 
reported similar effects for both intrusive thoughts and posttraumatic cognitions on psychosocial health 
among cancer patients and survivors using the eight-item intrusive thoughts subscale of the Impact of Event 
Scale (IES; Horowitz, Wilner, & Alvarez, 1979).  
Posttraumatic cognitions play an important role in the theoretical framework of posttraumatic growth. 
Specifically the transformation of automatic ruminations, posttraumatic cognitions, and intrusive thoughts 
with a negative valence into deliberate, growth-oriented, positive narrative developing intentional thoughts 
is central to Tedeschi and Calhoun's (2004) model of the psychosocial process by which posttraumatic 
growth develops. Thus, the current study evaluated the relative effect of posttraumatic cognitions, and the 
interaction of posttraumatic growth and posttraumatic cognitions on the three health outcomes. 
Posttraumatic cognitions were associated with the three health outcomes, while controlling for 
posttraumatic stress symptoms and posttraumatic growth. These results bolster previous research reporting 
associations between intrusive thoughts and bio-psychosocial health among cancer patients and survivors 
(Vickberg et al., 2000; Whitaker et al., 2009). For example, Whitaker and colleagues (2009) report that 
nearly 50% of anxious cancer patients in their study had frequent uncontrollable intrusive cognitions that 
were associated with severity of depression. Additionally, the current study extends previous research by 
establishing an association between the construct of posttraumatic cognitions (per se) and distress about 
physical health symptoms and quality of life among cancer patients.  
Personal growth initiative. Personal growth has been described as a process by which 
developmental, environmental, and intentional experiences act as a catalyst for continued personal growth 
that produces positive personal change and development across the lifespan (Robitschek, 1998). When 
personal growth is stimulated by a traumatic environmental event or process such as the cancer experience, 
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it can be interpreted as posttraumatic growth (Tedeschi & Calhoun, 1995). Thus, this study evaluated the 
relative effect of personal growth initiative, posttraumatic stress symptoms, posttraumatic growth and the 
interaction of personal growth initiative with posttraumatic stress symptoms on the three health outcomes. 
Results indicate that personal growth initiative was associated with better quality of life and fewer 
depressive symptoms while controlling for PTSD symptoms and posttraumatic growth. Additionally, in this 
analysis, posttraumatic growth was not associated with any of the three health outcomes and personal 
growth initiative appeared to buffer the relation between posttraumatic stress symptoms and quality of life. 
These results highlight the importance of assessing personal growth in addition to posttraumatic growth in 
future research attempting to elucidate the potential positive outcomes of inherently negative life 
experiences.  
Depressive symptoms. As discussed by Clark and Watson (1991) there is considerable overlap 
between the symptoms of anxiety disorders such as PTSD and depression. Given the substantial overlap in 
symptoms of depression and PTSD, and the elevated levels of depressive and posttraumatic stress 
symptoms reported by participants in the current study, it is important to evaluate the extent to which 
current depression affects bio-psychosocial health among cancer survivors. Thus, the current study 
evaluated the relative effect of depressive symptoms on distress about physical health symptoms and 
quality of life.  
The results indicate that depressive symptoms were associated with increased distress about physical 
health and poorer quality of life while controlling for posttraumatic stress symptoms and posttraumatic 
growth. The prevalence of depressive symptoms in this sample and the association between those 
symptoms and health outcomes are consistent with previous research (Derogatis et al., 1983; Harrison et 
al., 1994; Mehnert & Koch, 2007). Meaning that in addition to PTSD symptoms, many cancer survivors 
have clinically significant levels of depressive symptoms that often begin shortly after diagnosis and may 
last for years following the conclusion of treatment. These findings again highlight the importance of 
adequate psychological screening in research and clinical settings leading to diagnostic assessment and 
treatment when appropriate.  
When taken as a whole, the results previously described indicate that in addition to PTSD symptoms 
and posttraumatic growth, posttraumatic cognitions, personal growth initiative, and perceived stress were 
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the strongest correlates of bio-psychosocial health among cancer survivors. Future longitudinal research 
may be beneficial in elucidating causal relations between and among these constructs and well-being in 
cancer patients and survivors. 
The Real and Illusory Nature of Posttraumatic Growth 
Conflict continues over the real or illusory nature of the construct of posttraumatic growth. Some 
researchers view posttraumatic growth as real developmental growth and positive modification of one's 
personal identity that extends beyond a patient’s pre-morbid level of functioning. It is seen as a result of the 
struggle with the traumatic experience rather than the changes caused by the experience itself (Tedeschi & 
Calhoun, 1995). Conversely, others view posttraumatic growth as illusory and liken it to avoidant based 
coping focused on finding meaning in an adverse event. This is viewed as an attempt to maintain the 
perception of internal locus of control while trying to bolster self-esteem and a personal sense of value 
(Taylor & Armor, 1996). As Sumalla and colleagues (2009) describe it, one of the central concepts of the 
argument that posttraumatic growth may be illusory is found in the occurrence of negative distortion of 
perception of past function. This distortion has potential for erroneous perception of improvement 
following a traumatic life experience, and misattribution of that perceived improvement as posttraumatic 
growth. For example, Widows and colleagues (2005) reported that the results of their longitudinal study of 
bone marrow transplant patients indicate that negatively distorted perceptions of pre-procedure 
psychological distress were associated with higher post-procedure reports of posttraumatic growth.  
Sumalla and colleagues (2009) conclude that quantifying objectively the subjective experience of 
positive identity change is impossible. Therefore, we are left with the question as to whether it is more 
therapeutically appropriate to attempt to destroy potential illusions of personal growth through adversity or 
to assist patients in adaptively coping with their trauma by helping them to engage in cognitive 
restructuring of the meaning of their cancer experience. Given the potential for differences in the cancer 
experience of the estimated 12 million cancer survivors and the plausibility of both sides of this argument, 
it is likely that posttraumatic growth is illusory for some, real for others, and both illusory and real for 
many depending on how far along they are on their journey through cancer survivorship.  The existence of 
this controversy highlights the need for continued longitudinal or RCT studies, and the creation and 
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implementation of measures of growth following adversity that are more objective, perhaps in the form of 
third-party report, or measures that assess quantifiable milestones in development across the lifespan. 
Limitations 
 The cross-sectional design of the current study limits our ability to infer causal relations among 
the study constructs.  Distress about physical symptoms, quality of life, or depressive symptoms may affect 
posttraumatic growth and posttraumatic stress symptoms or an unmeasured variable may be the causal link 
to all of these constructs. In addition to the cross-sectional design, the current study has several 
shortcomings that fall into four broad categories: sample-related difficulties; shortcomings with measures 
and data collection; difficulties related to data analysis; and potential confounding factors or other variables 
or measures that were not measured.   
Sample related shortcomings. Of the 237 potential participants that voluntarily responded and were 
eligible to participate, 29% (n = 69) decided not to enroll in the study. The percentage of eligible 
participants that voluntarily responded who participated in the current study was 71% which is higher than 
the 43.5% rate reported by Owen and colleagues (2005). Experience has demonstrated that many cancer 
survivors participate in psychological research because of an interest in the research topic, an internal sense 
of curiosity, or a sense of duty.  By withholding information about compensation in the initial call for 
participants and screening documents, I intentionally attempted to avoid enrolling participants who would 
only complete the questionnaire in order to receive the $10 amazon.com gift card without thoughtfully 
answering the questions or perhaps without even being cancer survivors. Thus the number of potential 
participants who voluntarily responded and subsequently the number of participants in the study could have 
been increased by disclosing information about compensation in the initial call for participants and 
screening form.  
The study sample was extremely homogeneous with regard to gender, race, education, and financial 
status, while simultaneously being heterogeneous with regard to type of cancer and time since diagnosis.  
This pattern of variation, and lack thereof, presented problems regarding generalizability and inflated 
variance.  On one hand, the homogeneity of the sample with regard to demographic variables provides little 
in the way of generalizability, while the heterogeneity with regard to medical variables most likely 
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increased the variance in both the independent and dependent variables.  Future studies should attempt to 
achieve greater heterogeneity with regard to demographic variables.  A much larger sample, of perhaps 
1000 or more (which is possible with Internet-based data collection), may accomplish both of these goals 
and potentially allow for comparisons between types and perhaps stages of cancer. 
Measures-related shortcomings. The current study relied entirely on self-report measures. As such, 
the associations reported herein may be inflated, and therefore suspect due to common method variance. As 
evidenced by the results of analyses to establish convergent and discriminant validity, there was a great 
deal of inter-correlation between measures. Although results indicate adequate convergent and discriminant 
validity, analyses to establish construct validity may have benefitted from use of non-self-report measures 
used in previous research such as assessment of serum cortisol (Porter et al., 2003). Porter and colleagues 
(2003) explored the relations between cortisol levels and reactivity and several psychosocial constructs 
among breast cancer survivors. Although they reported no significant association between any of the 
cortisol measures and the paper and pencil version of the same measure of perceived stress used in the 
current study, they found associations between cortisol reactivity and both perceived risk and positive 
affect. These results indicate the inherent value of using non-self-report measures in conjunction with self-
report measures to assess well-being in cancer survivors. 
Additionally, self-report measures are subjective, and therefore may not represent an objective 
assessment of symptoms. For example, Kangas and colleagues (2002) report that between 5% and 19% of 
cancer patients and survivors were likely to meet diagnostic criteria for PTSD based on self-report 
assessment measures similar to the measure used in the current study. However, estimates of the prevalence 
of PTSD in cancer survivors is lower, 0%-6%, when using structured clinical interviews to assess DSM-IV 
criteria (Kangas et al., 2002).  Thus, self-report measures may be better for screening than diagnosis, as 
they have increased sensitivity and decreased specificity.  
The assessment of distress about physical health symptoms also presented some measure-related 
shortcomings. Specifically, a modified version of the Cohen-Hoberman Inventory of Physical Symptoms 
(CHIPS; S. Cohen & Hoberman, 1983) was used for the current study. In this instrument, a symptom 
checklist was integrated with the items assessing distress about physical symptoms. Visual inspection of the 
raw data from the CHIPS revealed a pattern of participants responding to the distress about physical 
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symptoms on the CHIPS scale only for symptoms they had previously indicated experiencing during the 
preceding two weeks. Future research designed to assess the incidence of physical symptoms, in addition to 
the distress caused by them, could employ two separate but parallel measures, one to assess incidence of  
physical symptoms one to assess distress about those physical symptoms. 
Data analysis. To test the primary hypotheses, post hoc models and explicate the significant 
interaction, the current study employed a somewhat complex data analysis strategy requiring more than 80 
separate analyses. This included 30 individual MANOVA and one simultaneous linear regression. The 
analytic strategy for the alternative models was viewed as a single omnibus MANOVA and five sets of 
subsequent post-hoc analyses to explore the effects of each variable in more detail than was possible in the 
omnibus model. The results of the subsequent models exploring the individual predictors were consistent 
with the findings from the initial omnibus model; however, the initial model regressed three outcome 
variables on twelve predictors. Even though the current study had 165 participants and the ratio of 
participants to predictors falls within the generally accepted range of 10 - 20 participants per predictor, it 
falls in the lower end of the recommended range (Peduzzi, Concato, Kemper, Holford, & Feinstein, 1996). 
Future research may be better served a larger sample and/or fewer variables, or by the use of more 
sophisticated analytic methods such as structural equation modeling, which would allow both exploratory 
and confirmatory modeling with the potential to test causal inferences. 
 Potential confounding factors or other missing variables or measures. Several groups of 
researchers have explored the relations between intrusive thoughts and health outcomes (e.g. Bleiker et al., 
2000; Kazak et al., 2004; Lechner, Carver, Antoni, Weaver, & Phillips, 2006; Lewis et al., 2001; Manne et 
al., 2004; Park et al., 2010; Vickberg et al., 2000; Whitaker et al., 2009). Rather than use an omnibus 
measure of PTSD symptoms, many of these researchers have used the intrusive thoughts subscale of the 
Impact of Events Scale (IES; Horowitz et al., 1979). Several studies have explored moderation models with 
the constructs of negative appraisal, global meaning, and posttraumatic growth (Park et al., 2010; Vickberg 
et al., 2000; Whitaker et al., 2009).  For example, Park and colleagues (2010) reported that among the 
younger adult cancer survivors, posttraumatic growth buffered the relations between intrusive thoughts and 
positive and negative affect, life satisfaction, and spiritual well-being. The inclusion of a measure of 
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intrusive thoughts (per se) would have added breadth to the findings on the relations between the 
multifaceted factors of posttraumatic stress and bio-psychosocial health among cancer survivors. 
Implications for Future Research 
Results of the current study have implications for future research with regard to the mechanisms 
involved in the association between posttraumatic stress and health, and the use of online methodology to 
explore those mechanisms.  The current study demonstrated that the online data collection system created 
for the study is a reliable and valid measure of posttraumatic stress, posttraumatic growth and bio-
psychosocial health among cancer survivors. If used in conjunction with physiological measures or 
neuropsychological assessment, it could be an integral part of the process of elucidating the relations 
between and among posttraumatic and perceived stress, posttraumatic growth, and health outcomes among 
cancer patients and survivors.  Future research might also focus on longitudinal studies exploring causal 
relations and mediation models between and among posttraumatic stress, posttraumatic growth, 
posttraumatic cognitions, intrusive thoughts, personal growth and well being among cancer survivors.    
The current study used an entirely online data collection methodology that may allow researchers to 
collect data from increasing numbers of participants, from potentially global geographic areas, in 
naturalistic settings with minimal experimental impact on participants. In this study, participants completed 
the questionnaire from as far away as Mexico, British Columbia, and the UK. More than 75,000 data points 
were collected, entered, and coded from 165 participants in about 100 days with no data entry errors and 
only .01% missing data.  
Similar to Bauer and colleagues (2004), this study showed that relatively large scale data collection, 
entry and coding could be accomplished with a substantial reduction in labor, expense, missing data, and 
data entry errors when compared with traditional paper and pencil survey methodology. The data for the 
current study was collected from only 165 participants; however, after the initial design and 
implementation of the online data collections system, it could have easily been 1,650 participants given 
sufficient resources (money and time) for recruitment and compensation of participants, with very little 
additional effort with regard to data coding, entry, management, and analysis. Additionally, the online data 
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collection system created for the current study has implications for future research in conjunction with 
neuropsychological assessment and physiological measures such as serum cortisol. 
Implications for Clinical Practice  
Of the 47 participants that reported clinically significant levels of depressive and/or PTSD symptoms 
only 27 (57%) reported having a history of receiving treatment for a psychiatric disorder. Thus, 43% of 
participants who reported clinically significant symptoms of a psychiatric disorder within two weeks of 
participating in the study reported never having received treatment. These results bolster previous research 
by Kadan-Lottick and colleagues (2005) indicating that up to 50% of cancer survivors who meet criteria for 
a DSM-IV psychiatric disorder do not readily access mental health services, and  highlight the importance 
of screening, diagnostic assessment, and subsequent treatment of psychiatric disorders in cancer survivors 
in clinical settings.   
Given the link between posttraumatic stress and health, and the relatively high levels of posttraumatic 
stress symptoms in this sample there are also important implications for clinical practice. Specifically, 
screening of all cancer patients and survivors for PTSD and depressive symptoms should be standard care. 
Following a positive screen for either PTSD or depression, patients should be referred for diagnostic 
assessment and subsequent implementation of empirically supported treatments. These include exposure-
based treatments for PTSD such as prolonged exposure or cognitive processing therapy or cognitive 
behavior therapy for depression.  
Although the size of the associations between posttraumatic and personal growth and well-being in the 
current study were relatively small when compared with PTSD symptoms or posttraumatic cognitions, 
previous research has demonstrated an association between increased personal growth, peer support, social 
support, and well-being (Dunn, Campbell, Penn, Dwyer, & Chambers, 2009; Love & Sabiston, 2011). 
Thus, clinical interventions designed to increase the experience of positive identity change may be of 
benefit to cancer patients and survivors across the cancer continuum. Thus, interventions focused on peer 
and social support may be effective in fostering increased developmental growth. 
Internet-based data collection systems similar to the one used in the current study may have important 
implications regarding screening, referral for diagnostic assessment, and subsequent treatment of 
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psychiatric disorders. This line of translational research could effectively bring information and referral 
resources to populations who, as the current study and previous research indicate, have significant 
psychiatric co-morbidity but do not readily access mental health services (Kadan-Lottick et al., 2005).  
Additionally, the data collection system designed for the current study may be a useful tool for use in 
data collection and assessment in clinical care. Of particular interest is the potential for its use in ongoing 
assessment in both face-to-face and telehealth-based treatment across the cancer continuum. 
Conclusion 
In the current study, PTSD symptoms, posttraumatic cognitions, personal growth initiative 
posttraumatic growth, and perceived stress were the strongest predictors of bio-psychosocial health among 
cancer survivors. Additionally, results indicate it is likely that having more expendable income affords 
cancer survivors access to greater resources with which to cope with cancer and non-cancer related 
stressors.  
The results of the current study supports previous research indicating that between 5% and 19% of 
those suffering from cancer may meet diagnostic criteria for PTSD, which often persists for many years 
after treatment is completed, and is associated with higher levels of distress about physical health 
symptoms, lower quality of life and higher levels of depressive symptoms (Kangas et al., 2002). 
Additionally, results of the current study bolster previous research that has reported as many as 50% of 
cancer survivors who report clinically significant symptoms of a psychiatric disorder do not readily access 
mental health services (Kadan-Lottick et al., 2005).  
Although, debate over the real or illusory nature of the construct of posttraumatic growth continues, 
interventions designed to increase the experience of positive identity change may be of benefit to cancer 
patients and survivors. These results highlight the importance of using a multifaceted approach in assessing 
both posttraumatic stress symptoms and posttraumatic growth in both research and multidisciplinary health 
care settings. 
The results of this study suggest that the online data collection system designed for the study is a 
feasible, reliable, and useful tool to assess distress about physical health symptoms, quality of life, and 
depressive symptoms in cancer survivors. Internet-based data collection may have important implications 
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regarding screening and referral for treatment of psychiatric disorders in research and clinical care, 
especially with regard to ongoing assessment in face-to-face and telehealth-based provision of clinical 
services. 
Thus, in light of the rapidly growing population of long-term cancer survivors, these results are 
especially important to both short-term functioning of cancer patients and long-term outcomes in cancer 
survivors (National Cancer Institute, 2010).  
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FIGURES 
Figure 1.  Model for the Interaction between Posttraumatic Growth and Posttraumatic Stress Symptoms in 
Predicting Health Outcomes. 
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Figure 2.  Model for the Interaction between Perceived Stress and Posttraumatic Stress Symptoms in 
Predicting Health Outcomes. 
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Figure 3. Explication of the interaction between personal growth initiative and posttraumatic stress 
symptoms on quality of life. 
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TABLES 
Table 1 
 Means, Standard Deviations, and 95% Confidence Intervals (95% CI) for Predictor and Outcome Variables. 
 Mean SD (95% CI) 
Primary Predictor Variables    
Posttraumatic Stress Symptoms (PCL-C) 32.24 12.15 (30.37 - 34.11) 
Posttraumatic Growth (PTGI) 27.22 22.36 (61.88 - 68.30) 
Perceived Stress (E-VAS-Stress) 27.21 22.36 (23.78 - 30.66) 
Primary Outcome Variables    
Distress About Physical Health Symptoms (RSCL-PS) 30.01 6.56 (29.00 - 31.02) 
Quality of Life (FACT-G) 82.86 17.61 (80.15 - 85.56) 
Depressive Symptoms (CES-D) 21.08 12.74 (10.96 - 14.51) 
Variables to Test Alternate Models    
Posttraumatic Cognitions (PTCI) 60.48 24.92 (56.65 - 64.31) 
Personal Growth Initiative (PGIS) 38.76 9.25 (37.34 - 40.19) 
Rumination 14.75 4.81 (14 - 15.5) 
Note: PCL-C = Posttraumatic Stress Checklist - Civilian Version; PTGI = Posttraumatic Growth Inventory;   PTCI = Posttraumatic Cognitions 
Inventory; PGIS = Personal Growth Initiative Scale; RSCL-PS = The Rotterdam Symptom Checklist - Physical Symptoms Subscale; CES-D = The 
Center for Epidemiological Studies - Depression Measure; FACT-G = Functional Assessment of Cancer Therapy Scale. 
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Table 2 
Correlations between Predictor and Outcome Variables to Establish Construct Validity 
 Primary Predictor Variables Primary Outcome Variables Variable for Alternative Models 
 PCL-C PTGI Stress RSCL FACT CES-D RUM PTCI PGIS 
PCL-C ---- -.06 .42** .62** -.71** .79** .54** .73** -.58** 
PTGI  ---- -.08 -.02 .20* -.20** .04 -.17* .33** 
Stress   ---- .35** -.39** .47** -.66** .38** -.33** 
RSCL    ---- -.78** .65** -.42** .54** -.41** 
FACT     ---- -.78** -.33** -.73** .64** 
CES-D      ---- -.64** .75** -.64** 
RUM       ---- .39** -.33** 
PTCI        ---- -.66** 
PGIS         ---- 
Note: *p < 0.05; ** p < 0.01; PCL-C = Posttraumatic Stress Checklist - Civilian Version; PTGI = Posttraumatic Growth Inventory;   RSCL = Rotterdam 
Symptom Checklist - Physical Symptoms Subscale; FACT-G = Functional Assessment of Cancer Therapy Scale; CES-D = The Center for 
Epidemiological Studies - Depression Measure; RUM = Rumination Scale; PTCI = Posttraumatic Cognitions Inventory; and PGIS = Personal Growth 
Initiative Scale. 
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Table 3 
Comparison of Results of Internal Reliability Analysis between the Current Study and Previous Research 
 Cronbach's Alpha 
 Current Study Previous Research 
Posttraumatic Stress Symptoms (PCL-C) .92 .94 
Posttraumatic Growth (PTGI) .94 .90-.96 
Distress about Physical Symptoms (RSCL-
PS) 
.79 .82 - .87 
Quality of Life (FACT-G) .92 .86 - .89 
Depressive Symptoms (CES-D) .94 .84 - .90 
Rumination .84 Not available 
Posttraumatic Cognitions(PTCI) .94 .86 - .97 
Personal Growth Initiative (PGIS) .92 .90 
Note: PCL-C = PTSD Checklist - Civilian Version; PTGI = Posttraumatic Growth Inventory;   RSCL-PS = Rotterdam Symptom Checklist - Physical 
Symptoms Subscale; FACT-G = Functional Assessment of Cancer Therapy Scale CES-D = The Center for Epidemiological Studies - Depression 
Measure; PTCI = Posttraumatic Cognitions Inventory; PGIS = Personal Growth Initiative Scale. 
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Table 4 
Bivariate Correlations (Pearson's r and Spearman's Rho) between Demographic/Medical and Outcome Variables to Inform Models  
 
Physical 
Symptoms 
Quality of 
Life 
Depressive 
Symptoms 
Posttraumatic 
Stress  
Posttraumatic 
Growth 
Perceived 
Stress 
Age .01 .05 -.17* -.20* .18* -12 
Gender .17* -.08 .09 .15* .08 .07 
Education Level 
(Rho) -.12 .06 -.01 -.05 -.15 -.007 
Marital Status -.08 .27** -.32** -.30** .14 -.19* 
Financial Status (Rho) -.26** .29** -.28** -.29** -04 -.23** 
Time Since Diagnosis .12* -.20* .04 -.01 .03 -.05 
Chemotherapy -.01 -.00 .00 .01 .23** .07 
Time Since Treatment .14 -.16* .01 -.01 .02 -.05 
Note: *p < 0.05; ** p < 0.01; Statistic for Education Level and Financial Status is Spearman's Rho; all others are Pearson's r. 
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Table 5 
F and p-values from MANOVA Regressing Health Outcomes on Demographic and Medical Variables 
 
 
  
Distress About 
Physical Symptoms Quality of Life 
Depressive 
Symptoms 
Variable (df1,df2) F p F p F p 
Step 1 
Corrected Model (6,156) 5.424 .000 7.179 .000 8.208 .000 
Age (1,156) .038 .846 .607 .437 4.333 .039 
Gender (1,156) 4.956 .027 .094 .760 .055 .815 
Education (1,156) 2.440 .120 1.253 .265 .522 .471 
Marital Status (1,156) .078 .781 10.373 .002 15.752 .000 
Financial Status (1,156) 15.419 .000 16.108 .000 18.998 .000 
Time Since Diagnosis (1,156) 2.513 .115 4.707 .032 .056 .814 
Step 2 
Corrected Model (5,157) 5.97 .000 8.35 .000 9.78 .000 
Age (1,157) .08 .776 .51 .476 4.19 .042 
Gender (1,157) 4.66 .032 .07 .792 .04 .836 
Marital Status (1,157) .02 .898 9.77 .002 15.40 .000 
Financial Status (1,157) 18.35 .000 18.51 .000 21.04 .000 
Time Since Diagnosis (1,157) 2.72 .101 4.93 .028 .07 .788 
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Table 6 
F and p-values from MANOVA Regressing Health Outcomes on Posttraumatic Stress Symptoms, Posttraumatic Growth and the Interaction of 
Posttraumatic Growth and Posttraumatic Stress Symptoms 
    
Distress About 
Physical Symptoms Quality of Life 
Depressive 
Symptoms 
Variable (df1,df2) F p F p F p 
Hypothesis 1a   
Corrected Model (6,156) 21.73 0.000 34.34 0.000 49.97 0.000 
Age (1,156) 4.27 0.040 1.40 0.238 0.16 0.688 
Gender (1,156) 3.51 0.063 0.39 0.534 0.78 0.380 
Marital Status (1,156) 5.31 0.023 1.04 0.309 3.72 0.056 
Financial Status (1,156) 3.88 0.051 2.96 0.088 3.52 0.063 
Time Since Diagnosis (1,156) 5.01 0.027 10.48 0.001 0.48 0.489 
PTSD Symptoms (PCL-C) (1,156) 84.66 0.000 129.98 0.000 191.60 0.000 
Hypothesis 1b   
Corrected Model (7, 155) 18.65 0.000 33.24 0.000 47.30 0.000 
Age (1,155) 4.68 0.032 3.45 0.065 0.05 0.821 
Gender (1,155) 3.79 0.053 0.04 0.837 0.23 0.632 
Marital Status (1,155) 5.71 0.018 0.20 0.653 1.93 0.167 
Financial Status (1,155) 4.03 0.046 3.96 0.048 4.59 0.034 
Time Since Diagnosis (1,155) 4.93 0.028 10.82 0.001 0.43 0.511 
PTSD Symptoms (PCL-C) (1,155) 84.36 0.000 138.90 0.000 204.01 0.000 
Posttraumatic Growth 
(PTGI) 
(1,155) 0.52 0.470 12.04 0.001 11.36 0.001 
Hypothesis 1c   
Corrected Model (8,154) 16.28 0.000 28.90 0.000 42.25 0.000 
Age (1,154) 4.45 0.036 3.38 0.068 0.12 0.725 
Gender (1,154) 3.40 0.067 0.05 0.831 0.06 0.807 
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Marital Status (1,154) 5.41 0.021 0.21 0.651 1.55 0.215 
Financial Status (1,154) 4.31 0.040 3.86 0.051 3.24 0.074 
Time Since Diagnosis (1,154) 5.14 0.025 10.67 0.001 0.22 0.643 
PTSD Symptoms (PCL-C) (1,154) 83.01 0.000 133.57 0.000 190.51 0.000 
Posttraumatic Growth 
(PTGI) 
(1,154) 0.26 0.610 10.67 0.001 14.06 0.000 
Interaction (PTGI*PCL-C) (1,154) 0.33 0.568 0.01 0.936 2.88 0.091 
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Table 7 
F and p-values from MANOVA Regressing Health Outcome Variables on Perceived Stress, Posttraumatic Stress Symptoms, Posttraumatic Growth and 
the Interaction of Perceived Stress and Posttraumatic Stress Symptoms 
 
   
Distress About 
Physical Symptoms Quality of Life 
Depressive 
Symptoms 
Variable (df1,df2) F p F p F p 
Hypothesis 2a   
Corrected Model (6,156) 8.31 .000 10.89 .000 14.10 .000 
Age (1,156) 0.44 .508 0.13 .715 3.02 .084 
Gender (1,156) 4.73 .031 0.03 .855 0.01 .914 
Marital Status (1,156) 0.28 .600 6.56 .011 11.22 .001 
Financial Status (1,156) 11.98 .001 11.93 .001 13.40 .000 
Time Since Diagnosis (1,156) 4.06 .046 6.97 .009 0.43 .513 
Perceived Stress (1,156) 16.99 .000 18.86 .000 27.49 .000 
Hypothesis 2b   
Corrected Model (8, 154) 16.92 .000 29.67 .000 43.59 .000 
Age (1,154) 4.84 .029 3.55 .061 0.07 .794 
Gender (1,154) 3.84 .052 0.04 .838 0.24 .628 
Marital Status (1,154) 6.26 .013 0.13 .718 1.61 .206 
Financial Status (1,154) 3.29 .072 3.28 .072 3.55 .062 
Time Since Diagnosis (1,154) 5.52 .020 11.59 .001 0.70 .404 
Perceived Stress (E-VAS-Stress) (1,154) 3.07 .082 2.48 .118 6.31 .013 
PTSD Symptoms (PCL-C) (1,154) 65.02 .000 111.51 .000 162.62 .000 
Posttraumatic Growth (PTGI) (1,154) 0.39 .533 11.47 .001 10.72 .001 
Hypothesis 2c   
Corrected Model (9,153) 15.22 0.000 26.57 0.000 38.59 0.00 
Age (1,153) 5.28 0.023 3.94 0.049 0.09 0.76 
Gender (1,153) 3.40 0.067 0.05 0.831 0.06 0.81 
Marital Status (1,153) 5.84 0.017 0.20 0.658 1.69 0.20 
Financial Status (1,153) 3.40 0.067 3.39 0.068 3.58 0.06 
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Time Since Diagnosis (1,153) 6.13 0.014 12.41 0.001 0.80 0.37 
Perceived Stress (E-VAS-Stress) (1,153) 3.70 0.056 3.04 0.083 6.54 0.01 
PTSD Symptoms (PCL-C) (1,153) 65.78 0.000 110.94 0.000 155.41 0.00 
Posttraumatic Growth (PTGI) (1,153) 0.59 0.443 12.33 0.001 10.93 0.00 
Interaction (E-VAS-STRESS*PCL-C) (1,153) 1.33 0.250 1.32 0.253 0.27 0.60 
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Table 8 
F and p-values from MANOVA Regressing Health Outcome Variables on All Primary and Alternative Predictors  
 
   
Distress About 
 Physical Symptoms Quality of Life Depressive Symptoms 
Variable (df1,df2) F p F p F p 
Corrected Model (12,146) 11.86 .000 25.84 .000 34.99 .000 
Age (1,146) 3.32 .071 4.36 .039 0.32 .573 
Gender (1,146) 3.91 .050 0.20 .656 0.26 .613 
Marital Status (1,146) 6.15 .014 0.01 .926 0.15 .703 
Financial Status (1,146) 3.01 .085 2.00 .159 2.05 .154 
Time Since Diagnosis (1,146) 4.73 .031 7.92 .006 0.01 .904 
PTSD Symptoms (PCL-C) (1,146) 15.24 .000 18.90 .000 51.40 .000 
Posttraumatic Growth (PTGI) (1,146) 0.00 .979 3.06 .082 3.42 .066 
Perceived Stress (E-VAS-Stress) (1,146) 1.71 .193 0.80 .373 4.94 .028 
Rumination (RUM) (1,146) 2.29 .132 2.11 .148 1.90 .170 
Posttraumatic Cognitions (PTCI) (1,146) 2.65 .106 10.37 .002 10.05 .002 
Personal Growth Initiative (PGIS) (1,146) 0.00 .967 6.86 .010 7.50 .007 
Treatment for Psychiatric Disorder (PSY) (1,146) 1.50 .223 0.23 .631 1.74 .190 
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Table 9 
F and p-values from MANOVA Regressing Health Outcome Variables on Rumination 
   
Distress About 
Physical Symptoms Quality of Life 
Depressive 
Symptoms 
Variable (df1,df2) F p F p F p 
Step 1   
Corrected Model (6,156) 10.37 .000 13.83 .000 12.41 .000 
Age (1,156) 0.73 .396 0.03 .856 2.85 .093 
Gender (1,156) 2.31 .130 0.33 .567 0.20 .653 
Marital Status (1,156) 0.01 .942 10.19 .002 15.74 .000 
Financial Status (1,156) 13.30 .000 13.31 .000 16.04 .000 
Time Since Diagnosis (1,156) 4.65 .033 8.07 .005 0.36 .547 
Rumination (RUM) (1,156) 27.37 .000 32.76 .000 19.73 .000 
Step 2   
Corrected Model (8, 154) 16.85 .000 29.95 .000 41.25 .000 
Age (1,154) 4.89 .028 3.65 .058 0.05 .832 
Gender (1,154) 3.06 .082 0.18 .675 0.17 .684 
Marital Status (1,154) 4.98 .027 0.40 .530 1.75 .188 
Financial Status (1,154) 4.09 .045 4.02 .047 4.56 .034 
Time Since Diagnosis (1,154) 5.50 .020 11.81 .001 0.38 .540 
Rumination (RUM) (1,154) 2.80 .096 3.39 .067 0.34 .559 
PTSD Symptoms (PCL-C) (1,154) 51.38 .000 87.79 .000 159.79 .000 
Posttraumatic Growth (PTGI) (1,154) 0.68 .412 12.94 .000 11.05 .001 
Step 3   
Corrected Model (9,153) 14.90 .000 26.46 .000 36.45 .000 
Age (1,153) 4.80 .030 3.60 .060 0.05 .826 
Gender (1,153) 2.91 .090 0.19 .664 0.15 .702 
Marital Status (1,153) 4.99 .027 0.38 .536 1.76 .186 
Financial Status (1,153) 4.06 .046 4.00 .047 4.54 .035 
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Time Since Diagnosis (1,153) 5.54 .020 11.77 .001 0.36 .551 
Rumination (RUM) (1,153) 2.85 .093 3.41 .067 0.36 .549 
PTSD Symptoms (PCL-C) (1,153) 51.13 .000 87.03 .000 157.53 .000 
Posttraumatic Growth (PTGI) (1,153) 0.49 .484 11.48 .001 10.51 .001 
Interaction (PTGI*RUM) (1,153) 0.10 .756 0.04 .847 0.05 .829 
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Table 10 
F and p-values from MANOVA Regressing Health Outcome Variables on Posttraumatic Cognitions 
   
Distress About 
Physical Symptoms Quality of Life 
Depressive 
Symptoms 
Variable (df1,df2) F p F p F p 
Step 1   
Corrected Model (6,156) 15.59 .000 33.53 .000 37.78 .000 
Age (1,156) 1.21 .272 0.06 .815 2.38 .125 
Gender (1,156) 7.79 .006 0.66 .418 0.58 .449 
Marital Status (1,156) 4.95 .028 0.12 .735 1.69 .195 
Financial Status (1,156) 8.21 .005 6.93 .009 8.96 .003 
Time Since Diagnosis (1,156) 1.77 .186 4.38 .038 0.29 .588 
Posttraumatic Cognitions (PTCI) (1,156) 53.67 .000 126.16 .000 135.83 .000 
Step 2   
Corrected Model (8, 154) 17.33 .000 36.40 .000 49.15 .000 
Age (1,154) 4.20 .042 2.83 .094 0.00 .968 
Gender (1,154) 4.84 .029 0.10 .749 0.00 .993 
Marital Status (1,154) 7.60 .007 0.12 .725 0.48 .492 
Financial Status (1,154) 3.62 .059 3.40 .067 4.02 .047 
Time Since Diagnosis (1,154) 3.85 .052 8.41 .004 0.02 .889 
Posttraumatic Cognitions (PTCI) (1,154) 4.85 .029 24.03 .000 20.49 .000 
PTSD Symptoms (PCL-C) (1,154) 28.85 .000 36.07 .000 65.95 .000 
Posttraumatic Growth (PTGI) (1,154) 0.11 .743 7.76 .006 7.36 .007 
Step 3   
Corrected Model (9,153) 15.54 .000 32.16 .000 44.21 .000 
Age (1,153) 3.77 .054 2.86 .093 0.01 .928 
Gender (1,153) 4.46 .036 0.11 .739 0.01 .920 
Marital Status (1,153) 7.59 .007 0.12 .726 0.47 .492 
Financial Status (1,153) 3.76 .054 3.35 .069 3.84 .052 
Time Since Diagnosis (1,153) 4.11 .044 8.24 .005 0.00 .961 
Posttraumatic Cognitions (PTCI) (1,153) 5.76 .018 21.94 .000 16.41 .000 
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PTSD Symptoms (PCL-C) (1,153) 29.41 .000 35.61 .000 64.99 .000 
Posttraumatic Growth (PTGI) (1,153) 0.00 .962 7.51 .007 8.96 .003 
Interaction (PTGI*PTCI) (1,153) 1.16 .284 0.04 .833 2.03 .156 
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Table 11 
F and p-values from MANOVA Regressing Health Outcome Variables on Personal Growth 
   
Distress About 
Physical Symptoms Quality of Life 
Depressive 
Symptoms 
Variable (df1,df2) F p F p F p 
Step 1   
Corrected Model (6,156) 9.68 .000 24.13 .000 24.95 .000 
Age (1,156) 2.56 .112 2.45 .119 0.00 .955 
Gender (1,156) 8.43 .004 2.10 .149 1.82 .180 
Marital Status (1,156) 0.84 .360 3.28 .072 7.72 .006 
Financial Status (1,156) 10.01 .002 7.69 .006 9.77 .002 
Time Since Diagnosis (1,156) 1.35 .247 2.62 .108 0.54 .462 
Personal Growth Initiative (PGIS) (1,156) 23.88 .000 81.59 .000 77.11 .000 
Step 2   
Corrected Model (8, 154) 16.60 .000 35.71 .000 47.99 .000 
Age (1,154) 5.46 .021 7.01 .009 0.73 .393 
Gender (1,154) 4.52 .035 0.24 .623 0.02 .891 
Marital Status (1,154) 5.99 .016 0.08 .774 1.66 .199 
Financial Status (1,154) 3.29 .071 2.12 .147 2.74 .100 
Time Since Diagnosis (1,154) 4.01 .047 7.60 .007 0.00 .959 
Personal Growth Initiative (PGIS) (1,154) 1.69 .195 21.79 .000 17.53 .000 
PTSD Symptoms (PCL-C) (1,154) 54.04 .000 73.79 .000 120.51 .000 
Posttraumatic Growth (PTGI) (1,154) 0.06 .809 3.60 .060 3.69 .057 
Step 3   
Corrected Model (9,153) 14.91 .000 33.14 .000 42.42 .000 
Age (1,153) 5.11 .025 6.38 .013 0.69 .407 
Gender (1,153) 4.16 .043 0.11 .742 0.01 .910 
Marital Status (1,153) 4.91 .028 0.47 .496 1.74 .189 
Financial Status (1,153) 3.95 .049 3.47 .064 2.82 .095 
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Time Since Diagnosis (1,153) 4.28 .040 8.56 .004 0.00 .944 
Personal Growth Initiative (PGIS) (1,153) 1.66 .199 22.11 .000 17.39 .000 
PTSD Symptoms (PCL-C) (1,153) 52.41 .000 79.52 .000 105.73 .000 
Posttraumatic Growth (PTGI) (1,153) 0.14 .707 4.78 .030 3.76 .054 
Interaction (PGIS*PCL-C) (1,153) 1.20 .274 5.07 .026 0.10 .756 
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Table 12 
F and p-values from MANOVA Regressing Health Outcome Variables on Having a History of Treatment for a Psychiatric Disorder 
   
Distress About 
Physical Symptoms Quality of Life 
Depressive 
Symptoms 
Variable (df1,df2) F p F p F p 
Step 1   
Corrected Model (6,152) 6.90 .000 9.65 .000 9.51 .000 
Age (1,152) 0.04 .850 0.56 .457 4.32 .039 
Gender (1,152) 5.84 .017 0.23 .632 0.19 .666 
Marital Status (1,152) 0.01 .914 8.86 .003 13.76 .000 
Financial Status (1,152) 16.42 .000 16.67 .000 18.66 .000 
Time Since Diagnosis (1,152) 2.66 .105 4.85 .029 0.03 .865 
Treatment for Psychiatric Disorder 
(PSY) 
(1,152) 9.90 .002 13.57 .000 7.72 .006 
Step 2   
Corrected Model (8,150) 16.29 .000 28.82 .000 39.47 .000 
Age (1,150) 3.53 .062 3.05 .083 0.08 .783 
Gender (1,150) 4.00 .047 0.04 .847 0.20 .658 
Marital Status (1,150) 5.11 .025 0.34 .562 1.84 .177 
Financial Status (1,150) 4.02 .047 4.05 .046 4.53 .035 
Time Since Diagnosis (1,150) 4.85 .029 10.59 .001 0.38 .540 
Treatment for Psychiatric Disorder 
(PSY) 
(1,150) 2.75 .100 2.53 .114 0.04 .846 
PTSD Symptoms (PCL-C) (1,150) 70.24 .000 120.19 .000 182.92 .000 
Posttraumatic Growth (PTGI) (1,150) 0.04 .833 8.66 .004 10.05 .002 
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Table 13 
F and p-values from MANOVA Regressing Health Outcome Variables on Depressive Symptoms 
   
Distress About 
Physical Symptoms Quality of Life 
Variable (df1,df2) F p F p 
Step 1   
Corrected Model (6,156) 26.57 .000 45.39 .000 
Age (1,156) 4.19 .042 1.30 .256 
Gender (1,156) 6.92 .009 0.03 .870 
Marital Status (1,156) 8.77 .004 0.12 .732 
Financial Status (1,156) 2.68 .104 1.66 .200 
Time Since Diagnosis (1,156) 3.68 .057 8.81 .003 
Depressive Symptoms (CES-D) (1,156) 109.07 .000 182.35 .000 
Step 2   
Corrected Model (8, 154) 21.88 .000 39.96 .000 
Age (1,154) 4.98 .027 3.78 .054 
Gender (1,154) 5.19 .024 0.00 .998 
Marital Status (1,154) 9.61 .002 0.03 .869 
Financial Status (1,154) 1.65 .201 1.34 .248 
Time Since Diagnosis (1,154) 4.49 .036 11.00 .001 
Depressive Symptoms (CES-D) (1,154) 24.61 .000 35.40 .000 
PTSD Symptoms (PCL-C) (1,154) 7.50 .007 16.61 .000 
Posttraumatic Growth (PTGI) (1,154) 0.30 .586 4.61 .033 
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Table 14  
Percent of Variance (Adjusted R2) Accounted for by Each Hypothesis Model  
  Adjusted R2 (Adjusted R2 Change) 
Model RSCL-
PS 
FACT-
G 
CESD RSCL-
PS 
FACT-
G 
CESD 
Age, Gender, Marital Status, Financial Status, and 
Time since Diagnosis 
0.133 0.185 0.213 
------ ------ ------ 
Hypothesis 1 
H1a.  PCL-C 0.434 0.553 0.645 0.301 0.368 0.432 
H1c. PCL-C and PTGI 0.433 0.582 0.667 0.3 0.397 0.454 
         PTGI    -0.001 0.029 0.022 
H1d. PCL-C, PTGI and PTGI*PCL-C 0.43 0.579 0.671 0.297 0.394 0.458 
Hypothesis 2 
H2a. Perceived Stress 0.213 0.268 0.327 0.08 0.083 0.114 
H2b.  Stress, PCL-C,  and PTGI  0.44 0.586 0.678 0.227 0.318 0.351 
        PTGI    -0.002 0.028 0.02 
 2c. PCL-C,  PTGI, Stress, and E-VAS-Stress * PCL-C  0.441 0.587 0.676 0.308 0.402 0.463 
Note: PCL-C = Posttraumatic Stress Checklist - Civilian Version; PTGI = Posttraumatic Growth Inventory;   RSCL-PS = The Rotterdam Symptom 
Checklist - Physical Symptoms Subscale; FACT-G = Functional Assessment of Cancer Therapy Scale CES-D = The Center for Epidemiological Studies 
- Depression Measure; PTCI = Posttraumatic Cognitions Inventory; PGIS = Personal Growth Initiative Scale. 
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Table 15  
Percent of Variance (Adjusted R2) Accounted for by Post Hoc Models  
 Adjusted R2 (Adjusted R2 Change) 
Model RSCL-PS 
FACT-
G CESD 
RSCL-
PS 
FACT-
G CESD 
Age, Gender, Marital Status, Financial Status, and 
Time since Diagnosis 0.133 0.185 0.213 ------ ------ ------ 
Model 3: The Omnibus Model PCL_C, PTGI, 
Perceived Stress, PTCI, Rumination, PGIS and 
Psychiatric Treatment 
0.452 0.654 0.721 0.319 0.469 0.508 
Model 4  Rumination (RUM) 0.258 0.322 0.297 0.125 0.137 0.084 
     PCL-C,  PTGI and Rumination 0.439 0.588 0.665 0.306 0.403 0.452 
     PTGI    -0.001 0.031 0.021 
3c. PCL-C,  PTGI, RUM, and PTGI*RUM 0.436 0.586 0.663 -0.003 -0.002 -0.002 
Model 5  Posttraumatic Cognitions (PTCI) 0.351 0.546 0.577 0.218 0.361 0.364 
     PCL-C,  PTGI and PTCI 0.446 0.636 0.704 0.313 0.451 0.491 
     PTGI    -0.004 0.016 0.012 
     PCL-C,  PTGI, PTCI, and PTGI*PTCI 0.447 0.634 0.706 0.314 0.449 0.493 
Model 6  Personal Growth Initiative (PGIS) 0.243 0.461 0.47 0.11 0.276 0.257 
    PCL-C,  PTGI and PGIS 0.435 0.632 0.699 0.302 0.447 0.486 
     PTGI    -0.004 0.007 0.005 
     PCL-C,  PTGI, PGIS, and PGIS*PCL-C 0.436 0.641 0.697 0.303 0.456 0.484 
     PGIS*PCL-C     0.009  
Model 7 Previous Psychiatric Treatment (PSY) 0.183 0.247 0.244 0.05 0.062 0.031 
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     PCL-C,  PTGI and PSY 0.436 0.585 0.661 0.303 0.4 0.448 
     PTGI    -0.004 0.021 0.021 
Model 8  Depressive Symptoms (CES-D) 0.486 0.622 ------ 0.353 0.437 ------ 
CES-D, PCL-C, and PTGI 0.508 0.658 ------ 0.375 0.473 ------ 
     PTGI ------ ------ ------ -0.002 0.008 ------ 
Note: PCL-C = Posttraumatic Stress Checklist - Civilian Version; PTGI = Posttraumatic Growth Inventory;   RSCL-PS = The Rotterdam Symptom 
Checklist - Physical Symptoms Subscale; FACT-G = Functional Assessment of Cancer Therapy Scale CES-D = The Center for Epidemiological Studies 
- Depression Measure; PTCI = Posttraumatic Cognitions Inventory; PGIS = Personal Growth Initiative Scale. 
 
85 
 
REFERENCES 
Abercrombie, H. C., Giese Davis, J., Sephton, S., Epel, E. S., Turner Cobb, J. M., & Spiegel, D. (2004). 
Flattened cortisol rhythms in metastatic breast cancer patients. Psychoneuroendocrinology, 29(8), 1082-
1092.  
Abramowitz, J. S., Taylor, S., & McKay, D. (Eds.). (2008). Clinical handbook of obsessive-compulsive 
disorder and related problems. Baltimore, MD The Johns Hopkins University Press. 
Affleck, G., & Tennen, H. (1996). Construing benefits from adversity: adaptational significance and 
dispositional underpinnings. Journal of Personality, 64(4), 899-922.  
Aiken, L. S., & West, S. G. (1991). Multiple Regression: testing and interpreting interactions. Newbury 
Park, CA, USA: Sage Publications  
American Cancer Society. (2007). Cancer Facts and Figures 2007. Atlanta, GA. 
American Cancer Society. (2010). Cancer Facts and Figures 2010. Atlanta, GA. 
American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). 
Washington, DC: American Psychiatric Association. 
Andrykowski, M. A., Cordova, M. J., Studts, J. L., & Miller, T. W. (1998). Posttraumatic stress disorder 
after treatment for breast cancer: prevalence of diagnosis and use of the PTSD Checklist-Civilian Version 
(PCL-C) as a screening instrument. Journal of Consulting and Clinical Psychology, 66(3), 586-590.  
Antoni, M. H., Lehman, J. M., Kilbourn, K. M., Boyers, A. E., Culver, J. L., Alferi, S. M., et al. (2001). 
Cognitive-behavioral stress management intervention decreases the prevalence of depression and enhances 
benefit finding among women under treatment for early-stage breast cancer. Health Psychology, 20(1), 20-
32.  
Barakat, L. P., Kazak, A. E., Gallagher, P. R., Meeske, K., & Stuber, M. (2000). Posttraumatic stress 
symptoms and stressful life events predict the long-term adjustment of survivors of childhood cancer and 
their mothers. Journal of Clinical Psychology in Medical Settings, 7(4), 189.  
Bardwell, W. A., Major, J. M., Rock, C. L., Newman, V. A., Thomson, C. A., Chilton, J. A., et al. (2004). 
Health-related quality of life in women previously treated for early-stage breast cancer. Psycho-Oncology, 
13(9), 595-604.  
Bauer, M., Grof, P., Gyulai, L., Rasgon, N., Glenn, T., & Whybrow, P. C. (2004). Using technology to 
improve longitudinal studies: self-reporting with ChronoRecord in bipolar disorder. Bipolar Disorders, 
6(1), 67-74.  
Beck, J. G., Coffey, S. F., Palyo, S. A., Gudmundsdottir, B., Miller, L. M., & Colder, C. R. (2004). 
Psychometric properties of the Psttraumatic Cognitions Inventory (PTCI): A replication with motor vehicle 
accident survivors. Psychological Assessment, 16(3), 289.  
Bellizzi, K. M., Smith, A. W., Reeve, B. B., Alfano, C. M., Bernstein, L., Meeske, K., et al. (2010). 
Posttraumatic growth and health-related quality of life in a racially diverse cohort of breast cancer 
survivors. Journal of Health Psychology, 15(4), 615-626.  
Bleiker, E. M., Pouwer, F., van der Ploeg, H. M., Leer, J. W., & Ader, H. J. (2000). Psychological distress 
two years after diagnosis of breast cancer: frequency and prediction. Patient Education and Counseling, 
40(3), 209-217.  
Bliven, B. D., Kaufman, S. E., & Spertus, J. A. (2001). Electronic collection of health-related quality of life 
data: validity, time benefits, and patient preference. Quality of Life Research, 10(1), 15-22.  
86 
 
Brady, M. J., Cella, D. F., Mo, F., Bonomi, A. E., Tulsky, D. S., Lloyd, S. R., et al. (1997). Reliability and 
validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument. Journal of 
Clinical Oncology, 15(3), 974-986.  
Brown, R. T., Madan-Swain, A., & Lambert, R. (2003). Posttraumatic stress symptoms in adolescent 
survivors of childhood cancer and their mothers. Journal of Traumatic Stress, 16(4), 309-318.  
Calhoun, L. G., Cann, A., Tedeschi, R. G., & McMillan, J. (2000). A correlational test of the relationship 
between posttraumatic growth, religion, and cognitive processing. Journal of Traumatic Stress, 13(3), 521-
527.  
Calhoun, L. G., & Tedeschi, R. G. (2000). Early posttraumatic interventions: Facilitating possibilities for 
growth. . In R. G. Tedeschi, C. L. Park & L. G. Calhoun (Eds.), Posttraumatic growth: Positive changes in 
the aftermath of crisis. (pp. 215-238). Mahwah, NK: Erlbaum. 
Cantrell, M. A., & Lupinacci, P. (2007). Methodological issues in online data collection. Journal of 
Advanced Nursing, 60(5), 544-549.  
Carlson, L. E., Speca, M., Patel, K. D., & Goodey, E. (2003). Mindfulness-based stress reduction in 
relation to quality of life, mood, symptoms of stress, and immune parameters in breast and prostate cancer 
outpatients. Psychosomatic Medicine, 65(4), 571-581.  
Carson, J. W. (1999). Mindfulness meditation-based treatment for irritable bowel syndrome. PhD., , The 
University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.    
Cella, D. F., Tulsky, D. S., Gray, G., Sarafian, B., Linn, E., Bonomi, A., et al. (1993). The Functional 
Assessment of Cancer Therapy scale: development and validation of the general measure. Journal of 
Clinical Oncology, 11(3), 570-579.  
Clark, L. A., & Watson, D. (1991). Tripartite model of anxiety and depression: psychometric evidence and 
taxonomic implications. Journal of Abnormal Psychology, 100(3), 316-336.  
Cohen, L., Marshall, G. D., Jr., Cheng, L., Agarwal, S. K., & Wei, Q. (2000). DNA repair capacity in 
healthy medical students during and after exam stress. Journal of Behavioral Medicine, 23(6), 531-544.  
Cohen, M., & Numa, M. (2011). Posttraumatic growth in breast cancer survivors: A comparison of 
volunteers and non-volunteers. Psycho-oncology, 20(1), 69-76.  
Cohen, S., & Hoberman, H. M. (1983). Positive events and social supports as buffers of life change stress. 
Journal of Applied Social Psychology, 13(2), 99-125  
Cohen, S., Tyrrell, D. A., & Smith, A. P. (1993). Negative life events, perceived stress, negative affect, and 
susceptibility to the common cold. Journal of Personality and Social Psychology, 64(1), 131-140.  
Cohen, S., & Williamson, G. M. (1988). Perceived stress in a probability sample in the United States. In S. 
Spacapan & S. Oskamp (Eds.), The Social Psychology of Health. Newbury Park, CA  Sage. 
Cordova, M. J., & Andrykowski, M. A. (2003). Responses to cancer diagnosis and treatment: posttraumatic 
stress and posttraumatic growth. Seminars in Clinical Neuropsychiatry, 8(4), 286-296.  
Cordova, M. J., Andrykowski, M. A., Kenady, D. E., McGrath, P. C., Sloan, D. A., & Redd, W. H. (1995). 
Frequency and correlates of posttraumatic-stress-disorder-like symptoms after treatment for breast cancer. 
Journal of Consulting and Clinical Psychology, 63(6), 981-986.  
Cordova, M. J., Cunningham, L. L., Carlson, C. R., & Andrykowski, M. A. (2001a). Posttraumatic growth 
following breast cancer: A controlled comparison study. Health Psychology, 20(3), 176-185.  
87 
 
Cordova, M. J., Cunningham, L. L., Carlson, C. R., & Andrykowski, M. A. (2001b). Social constraints, 
cognitive processing, and adjustment to breast cancer. Journal of Consulting and Clinical Psychology, 
69(4), 706-711.  
Cordova, M. J., Giese-Davis, J., Golant, M., Kronenwetter, C., Chang, V., & Spiegel, D. (2007). Breast 
cancer as trauma: Posttraumatic stress and posttraumatic growth. Journal of Clinical Psychology in 
Medical Settings, 14(4), 308-319.  
Cordova, M. J., Studts, J. L., Hann, D. M., Jacobsen, P. B., & Andrykowski, M. A. (2000). Symptom 
structure of PTSD following breast cancer. Journal of Traumatic Stress, 13(2), 301-319.  
de Haes, J. C., & Olschewski, M. (1998). Quality of life assessment in a cross-cultural context: use of the 
Rotterdam Symptom Checklist in a multinational randomised trial comparing CMF and Zoladex (Goserlin) 
treatment in early breast cancer. Annals of Oncology, 9(7), 745-750.  
de Haes, J. C., van Knippenberg, F. C., & Neijt, J. P. (1990). Measuring psychological and physical distress 
in cancer patients: structure and application of the Rotterdam Symptom Checklist. British Journal of 
Cancer, 62(6), 1034-1038.  
DeLongis, A., Folkman, S., & Lazarus, R. S. (1988). The impact of daily stress on health and mood: 
psychological and social resources as mediators. Journal of Personality and Social Psychology, 54(3), 486-
495.  
Derogatis, L. R., Morrow, G. R., Fetting, J., Penman, D., Piasetsky, S., Schmale, A. M., et al. (1983). The 
prevalence of psychiatric disorders among cancer patients. The Journal of the American Medical 
Association, 249(6), 751-757. doi: 10.1001/jama.1983.03330300035030 
Dharma-Wardene, M., Au, H. J., Hanson, J., Dupere, D., Hewitt, J., & Feeny, D. (2004). Baseline FACT-G 
score is a predictor of survival for advanced lung cancer. Quality of Life Research, 13(7), 1209-1216.  
Drageset, S., & Lindstrom, T. C. (2003). The mental health of women with suspected breast cancer: the 
relationship between social support, anxiety, coping and defence in maintaining mental health. Journal 
Psychiatric and Mental Health Nursing, 10(4), 401-409.  
Dunn, J., Campbell, M., Penn, D., Dwyer, M., & Chambers, S. K. (2009). Amazon Heart: An exploration 
of the role of challenge events in personal growth after breast cancer. Journal of Psychosocial Oncology, 
27(1), 119 - 135.  
Edelman, S., Bell, D. R., & Kidman, A. D. (1999). A group cognitive behaviour therapy programme with 
metastatic breast cancer patients. Psycho-Oncology, 8(4), 295-305.  
Eiser, C., Havermans, T., Craft, A., & Kernahan, J. (1997). Validity of the Rotterdam Symptom Checklist 
in paediatric oncology. Medical and Pediatric Oncology 28(6), 451-454. doi: 10.1002/(SICI)1096-
911X(199706)28:6<451::AID-MPO11>3.0.CO;2-C [pii] 
Engel, G. L. (1977). The need for a new medical model: a challenge for biomedicine. Science, 196(4286), 
129-136.  
Fergusson, G., Hendry, J., & Freeman, C. (2003). Do patients who receive electroconvulsive therapy in 
Scotland get better? Results of a national audit. Psychiatric Bulletin, 27(4), 137-140.  
Ferrell, B. R., Dow, K. H., Leigh, S., Ly, J., & Gulasekaram, P. (1995). Quality of life in long-term cancer 
survivors. Oncology Nursing Forum, 22(6), 915-922.  
Foa, E. B., Ehlers, A., Clark, D. M., Tolin, D. F., & Orsillo, S. M. (1999). The Posttraumatic Cognitions 
Inventory (PTCI): Development and validation. Psychological Assessment, 11(3), 303.  
88 
 
Fogel, J., Albert, S. M., Schnabel, F., Ditkoff, B. A., & Neugut, A. I. (2003). Racial/ethnic differences and 
potential psychological benefits in use of the Internet by women with breast cancer. Psycho-Oncology, 
12(2), 107.  
Folkman, S., Lazarus, R. S., Gruen, R. J., & DeLongis, A. (1986). Appraisal, coping, health status, and 
psychological symptoms. Journal of Personality and Social Psychology, 50(3), 571-579.  
Forlenza, M. J., Latimer, J. J., & Baum, A. (2000). The effects of stress on DNA repair capacity. 
Psychology and Health, 15(6), 881-891.  
Fredrickson, B. L., Tugade, M. M., Waugh, C. E., & Larkin, G. R. (2003). What good are positive 
emotions in crisis? A prospective study of resilience and emotions following the terrorist attacks on the 
United States on September 11th, 2001. Journal of Personality and Social Psychology, 84(2), 365-376.  
Fuchs, E., Czeh, B., & Flugge, G. (2004). Examining novel concepts of the pathophysiology of depression 
in the chronic psychosocial stress paradigm in tree shrews. Behavioural Pharmacology 15(5-6), 315-325.  
Gant, J., Turner-Lee, N., Li, Y., & Miller, J. (2010). National minority broadband adoption: Comparative 
trends in adoption, acceptance and use. Retrieved from 
http://www.jointcenter.org/publications1/publication-PDFs/MTI_BROADBAND_REPORT_2.pdf 
Gil, K. M., Anthony, K. K., Carson, J. W., Redding-Lallinger, R., Daeschner, C. W., & Ware, R. E. (2001). 
Daily coping practice predicts treatment effects in children with sickle cell disease. Journal of Pediatric 
Psychology, 26(3), 163-173.  
Gil, K. M., Carson, J. W., Porter, L. S., Ready, J., Valrie, C., Redding-Lallinger, R., et al. (2003). Daily 
stress and mood and their association with pain, health-care use, and school activity in adolescents with 
sickle cell disease. Journal of Pediatric Psychology, 28(5), 363-373.  
Gil, K. M., Carson, J. W., Porter, L. S., Scipio, C., Bediako, S. M., & Orringer, E. (2004). Daily mood and 
stress predict pain, health care use, and work activity in African American adults with sickle-cell disease. 
Health Psychology, 23(3), 267-274.  
Gil, K. M., Mishel, M., Belyea, M., Germino, B., Porter, L., LaNey, I. C., et al. (2004). Triggers of 
uncertainty about recurrence and long-term treatment side effects in older African American and Caucasian 
breast cancer survivors. Oncology Nursing Forum, 31(3), 633-639.  
Giovagnoli, A. R. (1999). Quality of life in patients with stable disease after surgery, radiotherapy, and 
chemotherapy for malignant brain tumour. Journal of Neurology Neurosurgery and Psychiatry, 67(3), 358-
363.  
Glaser, R., Kiecolt-Glaser, J. K., Bonneau, R. H., Malarkey, W., Kennedy, S., & Hughes, J. (1992). Stress-
induced modulation of the immune response to recombinant hepatitis B vaccine. Psychosomatic Medicine, 
54(1), 22-29.  
Glaser, R., Thorn, B. E., Tarr, K. L., Kiecolt-Glaser, J. K., & D'Ambrosio, S. M. (1985). Effects of stress 
on methyltransferase synthesis: an important DNA repair enzyme. Health Psychology, 4(5), 403-412.  
Golden Kreutz, D. M., Browne, M. W., Frierson, G. M., & Andersen, B. L. (2004). Assessing stress in 
cancer patients: A second-order factor analysis model for the Perceived Stress Scale. Assessment, 11(3), 
216-223.  
Gotay, C. C., Isaacs, P., & Pagano, I. (2004). Quality of life in patients who survive a dire prognosis 
compared to control cancer survivors. Psycho-Oncology, 13(12), 882-892.  
Granello, D. H., & Wheaton, J. E. (2004). Online Data Collection: Strategies for Research. Journal of 
Counseling & Development, 82(4), 387.  
89 
 
Grant, M. M., Gil, K. M., Floyd, M. Y., & Abrams, M. (2000). Depression and functioning in relation to 
health care use in sickle cell disease. Annals of Behavioral Medicine, 22(2), 149-157.  
Green, B. L., Rowland, J. H., Krupnick, J. L., Epstein, S. A., Stockton, P., Stern, N. M., et al. (1998). 
Prevalence of posttraumatic stress disorder in women with breast cancer. Psychosomatics, 39(2), 102-111.  
Gurevich, M., Devins, G. M., Wilson, C., McCready, D., Marmar, C. R., & Rodin, G. M. (2004). Stress 
response syndromes in women undergoing mammography: a comparison of women with and without a 
history of breast cancer. Psychosomatic Medicine, 66(1), 104-112.  
Hann, D., Winter, K., & Jacobsen, P. (1999). Measurement of depressive symptoms in cancer patients: 
evaluation of the Center for Epidemiological Studies Depression Scale (CES-D). Journal of Psychosomatic 
Research, 46(5), 437-443.  
Hardy, J. R., Edmonds, P., Turner, R., Rees, E., & A'Hern, R. (1999). The use of the Rotterdam Symptom 
Checklist in palliative care. Journal of Pain and Symptom Management, 18(2), 79-84. doi: 
S0885392499000500 [pii] 
Harrison, J., Maguire, P., Ibbotson, T., MacLeod, R., & Hopwood, P. (1994). Concerns, confiding and 
psychiatric disorder in newly diagnosed cancer patients: A descriptive study. Psycho-oncology, 3(3), 173-
179. doi: 10.1002/pon.2960030303 
Hegel, M. T., Moore, C. P., Collins, E. D., Kearing, S., Gillock, K. L., Riggs, R. L., et al. (2006). Distress, 
psychiatric syndromes, and impairment of function in women with newly diagnosed breast cancer. Cancer, 
107(12), 2924-2931.  
Helgeson, V. S., Reynolds, K. A., & Tomich, P. L. (2006). A meta-analytic review of benefit finding and 
growth. Journal of Consulting and Clinical Psychology, 74(5), 797-816.  
Ho, S. M., Chan, C. L., & Ho, R. T. (2004). Posttraumatic growth in Chinese cancer survivors. Psycho-
oncology, 13(6), 377-389.  
Horowitz, M. J., Wilner, N., & Alvarez, W. (1979). Impact of Event Scale: A measure of subjective stress. 
Psychosomatic Medicine, 41(3), 209-218.  
Iconomou, G., Mega, V., Koutras, A., Iconomou, A. V., & Kalofonos, H. P. (2004). Prospective assessment 
of emotional distress, cognitive function, and quality of life in patients with cancer treated with 
chemotherapy. Cancer, 101(2), 404-411.  
Jacobsen, P. B., Sadler, I. J., Booth-Jones, M., Soety, E., Weitzner, M. A., & Fields, K. K. (2002). 
Predictors of posttraumatic stress disorder symptomatology following bone marrow transplantation for 
cancer. Journal of Consulting and Clinical Psychology, 70(1), 235-240.  
Janoff-Bulman, R., & Frantz, C. M. (1997). The impact of trauma on meaning: From meaningless world to 
meaningful life. In M. Power & C. R. Brewin (Eds.), The transformation of meaning in psychological 
therapies: Integrating theory and practices. New York: John Wiley & Sons. 
Kadan-Lottick, N. S., Vanderwerker, L. C., Block, S. D., Zhang, B., & Prigerson, H. G. (2005). Psychiatric 
disorders and mental health service use in patients with advanced cancer. Cancer, 104(12), 2872-2881. doi: 
10.1002/cncr.21532 
Kangas, M., Henry, J. L., & Bryant, R. A. (2002). Posttraumatic stress disorder following cancer. A 
conceptual and empirical review. Clinical Psychology Review, 22(4), 499-524.  
Kanner, A. D., Coyne, J. C., Schaefer, C., & Lazarus, R. S. (1981). Comparison of two modes of stress 
measurement: daily hassles and uplifts versus major life events. Journal of Behavioral Medicine, 4(1), 1-
39.  
90 
 
Kazak, A. E., Alderfer, M. A., Streisand, R., Simms, S., Rourke, M. T., Barakat, L. P., et al. (2004). 
Treatment of posttraumatic stress symptoms in adolescent survivors of childhood cancer and their families: 
A randomized clinical trial. Journal of Family Psychology, 18(3), 493.  
Lazarus, R. S. (1984). Puzzles in the study of daily hassles. Journal of Behavioral Medicine, 7(4), 375-389.  
Lazarus, R. S. (1993). Coping theory and research: past, present, and future. Psychosomatic  Medicine, 
55(3), 234-247.  
Lazarus, R. S., & Folkman, S. (1984). Stress, appraisal, and coping. New York: Springer Publishing 
Company. 
Lechner, S. C., Carver, C. S., Antoni, M. H., Weaver, K. E., & Phillips, K. M. (2006). Curvilinear 
associations between benefit finding and psychosocial adjustment to breast cancer. Journal of Consulting 
and Clinical Psychology, 74(5), 828-840.  
Lelorain, S., Bonnaud-Antignac, A., & Florin, A. (2010). Long term posttraumatic growth after breast 
cancer: Prevalence, predictors and relationships with psychological health. Journal of Clinical Psychology 
in Medical Settings, 17(1), 14-22.  
Lewis, J. A., Manne, S. L., DuHamel, K. N., Vicksburg, S. M. J., Bovbjerg, D. H., Currie, V., et al. (2001). 
Social support, intrusive thoughts, and quality of life in breast cancer survivors. Journal of Behavioral 
Medicine, 24(3), 231-245.  
Lillie, S. E., Brewer, N. T., O'Neill, S. C., Morrill, E. F., Dees, E. C., Carey, L. A., et al. (2007). Retention 
and use of breast cancer recurrence risk information from genomic tests: the role of health literacy. Cancer 
Epidemiology Biomarkers and Prevention, 16(2), 249-255.  
Linley, P. A., & Joseph, S. (2004). Positive change following trauma and adversity: a review. Journal of 
Traumatic Stress, 17(1), 11-21.  
Love, C., & Sabiston, C. M. (2011). Exploring the links between physical activity and posttraumatic 
growth in young adult cancer survivors. Psycho-oncology, 20(3), 278-286.  
Manne, S., Ostroff, J., Winkel, G., Goldstein, L., Fox, K., & Grana, G. (2004). Posttraumatic growth after 
breast cancer: patient, partner, and couple perspectives. Psychosomatic Medicine 66(3), 442-454.  
Mehnert, A., & Koch, U. (2007). Prevalence of acute and post-traumatic stress disorder and comorbid 
mental disorders in breast cancer patients during primary cancer care: a prospective study. Psycho-
oncology, 16(3), 181-188.  
Metzger, M. M., Kristof, V. L., & Yoest, D. J., Jr. (2003). The world wide web and the laboratory: A 
comparison using face recognition. CyberPsychology & Behavior, 6(6), 613.  
Mock, V., Pickett, M., Ropka, M. E., Muscari Lin, E., Stewart, K. J., Rhodes, V. A., et al. (2001). Fatigue 
and quality of life outcomes of exercise during cancer treatment. Cancer Practice, 9(3), 119-127.  
Mols, F., Vingerhoets, A. J. J. M., Coebergh, J. W. W., & van de Poll-Franse, L. V. (2009). Well-being, 
posttraumatic growth and benefit finding in long-term breast cancer survivors. Psychology & Health, 24(5), 
583-595.  
Morrill, E. F., Brewer, N. T., O’Neill, S. C., Lillie, S. E., Dees, E. C., Carey, L. A., et al. (2008). The 
interaction of posttraumatic growth and posttraumatic stress symptoms in predicting depressive symptoms 
and quality of life. Psycho-oncology, 17, 948-953.  
91 
 
Morrill, E. F., Richardson, E., Keith, J. R., & Puente, A. E. (2006). Predictive value of neuropsychological 
assessment; with regards to life expectancy among cardiac bypass surgery patients. Journal of Clinical 
Psychology in Medical Settings, 13(3), 332-336.  
National Cancer Institute. (2007a). About Cancer Survivorship: History  Retrieved 11/07/07, from 
http://dccps.nci.nih.gov/ocs/history.html  
National Cancer Institute. (2007b). Dictionary of Cancer Terms  Retrieved 11/07/07, from 
http://www.cancer.gov/templates/db_alpha.aspx?expand=C 
National Cancer Institute. (2010). SEER Cancer Statistics Review 1975 - 2004. Retrieved from 
http://seer.cancer.gov/csr/1975_2007/ 
National Cancer Institute. (2011a). Cancer Topics - Types of Treatment  Retrieved 04/01/2011, from 
http://www.cancer.gov/cancertopics/treatment/types-of-treatment 
National Cancer Institute. (2011b). SEER Cancer Statistics Review 1975 - 2008. Retrieved from 
http://seer.cancer.gov/csr/1975_2007/ 
National Cancer Institute (Ed.). (2007c). SEER Cancer Statistics Review 1975 - 2004: National Cancer 
Institute, Bethesda, MD. 
National Institutes of Health. (2008). Medical Encyclopedia: Stress and anxiety  Retrieved 4/16/08, from 
http://www.nlm.nih.gov/medlineplus/ency/article/003211.htm 
Nolen-Hoeksema, S., & Davis, C. G. (2002). Positive responses to loss: Perceiving benefits and growth. In 
C. R. Snyder & S. J. Lopez (Eds.), Handbook of positive psychology. New York: Oxford University Press. 
O'Neill, S. C., Brewer, N. T., Lillie, S. E., Morrill, E. F., Dees, E. C., Carey, L. A., et al. (2007). Women's 
interest in gene expression analysis for breast cancer recurrence risk. Journal of Clinical Oncology, 25(29), 
4628-4634.  
Ostir, G. V., Markides, K. S., Peek, M. K., & Goodwin, J. S. (2001). The association between emotional 
well-being and the incidence of stroke in older adults. Psychosomatic Medicine, 63(2), 210-215.  
Owen, J. E., Klapow, J. C., Roth, D. L., Shuster, J. L., Jr., Bellis, J., Meredith, R., et al. (2005). 
Randomized pilot of a self-guided internet coping group for women with early-stage breast cancer. Annals 
of Behavioral Medicine, 30(1), 54-64.  
Panter, A. T., & Reeve, B. B. (2002). Assessing tobacco beliefs among youth using item response theory 
models. Drug and Alcohol Dependence, 68(Suppl1), S21-S39.  
Park, C. L., Armeli, S., & Tennen, H. (2004). Appraisal-coping goodness of fit: a daily internet study. 
Personality & Social Psychology Bulletin, 30(5), 558-569.  
Park, C. L., Chmielewski, J., & Blank, T. O. (2010). Post-traumatic growth: finding positive meaning in 
cancer survivorship moderates the impact of intrusive thoughts on adjustment in younger adults. Psycho-
oncology, 19(11), 1139-1147. doi: 10.1002/pon.1680 
Park, C. L., Cohen, L. H., & Murch, R. L. (1996). Assessment and prediction of stress-related growth. 
Journal of  Personality 64(1), 71-105.  
Park, C. L., & Lechner, S. C. (2006). Measurement issues in assesing growth following stressful life 
experiences. In L. G. Calhoun, . & Tedeschi, R. G. (Ed.), Handbook of posttraumatic growth (pp. 47 - 67). 
Mahwah, NJ: Lawrence Erlbaum Associates, Inc. 
92 
 
Peduzzi, P., Concato, J., Kemper, E., Holford, T. R., & Feinstein, A. R. (1996). A simulation study of the 
number of events per variable in logistic regression analysis. Journal of Clinical Epidemiology, 49(12), 
1373-1379.  
Pereira, D. B., Antoni, M. H., Danielson, A., Simon, T., Efantis-Potter, J., Carver, C. S., et al. (2003). 
Stress as a predictor of symptomatic genital herpes virus recurrence in women with human 
immunodeficiency virus. Journal of Psychosomatic Research, 54(3), 237-244.  
Pettingale, K. W., Burgess, C., & Greer, S. (1988). Psychological response to cancer diagnosis: 
Correlations with prognostic variables. Journal of Psychosomatic Research, 32(3), 255-261.  
Porter, L. S., Clayton, M. F., Belyea, M., Mishel, M., Gil, K. M., & Germino, B. B. (2006). Predicting 
negative mood state and personal growth in African American and White long-term breast cancer 
survivors. Annals of Behavioral Medicine, 31(3), 195-204.  
Porter, L. S., Mishel, M., Neelon, V., Belyea, M., Pisano, E., & Soo, M. S. (2003). Cortisol levels and 
responses to mammography screening in breast cancer survivors: a pilot study. Psychosomatic Medicine, 
65(5), 842-848.  
Radloff, L. S. (1977). The CES-D Scale: A self-report depression scale for research in the general 
population. Applied Psychological Measurement, 1(3), 385-401.  
Reibel, D. K., Greeson, J. M., Brainard, G. C., & Rosenzweig, S. (2001). Mindfulness-based stress 
reduction and health-related quality of life in a heterogeneous patient population. General Hospital 
Psychiatry, 23(4), 183-192.  
Rimer, B. K., Halabi, S., Sugg Skinner, C., Lipkus, I. M., Strigo, T. S., Kaplan, E. B., et al. (2002). Effects 
of a mammography decision-making intervention at 12 and 24 months. American Journal of Preventive 
Medicine, 22(4), 247-257.  
Ritter, P., Lorig, K., Laurent, D., & Matthews, K. (2004). Internet versus mailed questionnaires: A 
randomized comparison. Journal of Medical Internet Research, 6(3).  
Robitschek, C. (1998). Personal growth initiative: The construct and its measure. Measurement and 
Evaluation in Counseling and Development, 30(4), 183-198.  
Salovey, P., Rothman, A. J., Detweiler, J. B., & Steward, W. T. (2000). Emotional states and physical 
health. American Psychologist, 55(1), 110-121.  
Salsman, J. M., Segerstrom, S. C., Brechting, E. H., Carlson, C. R., & Andrykowski, M. A. (2009). 
Posttraumatic growth and PTSD symptomatology among colorectal cancer survivors: A 3-month 
longitudinal examination of cognitive processing. Psycho-oncology, 18(1), 30-41.  
Schillewaert, N., & Meulemeester, P. (2005). Comparing response distributions of offline and online data 
collection methods. International Journal of Market Research, 47(2), 163.  
Schulz, U., & Mohamed, N. E. (2004). Turning the tide: benefit finding after cancer surgery. Social Science 
Medicine, 59(3), 653-662.  
Schwartz, L., & Drotar, D. (2006). Posttraumatic stress and related impairment in survivors of childhood 
cancer in early adulthood compared to healthy peers. Journal of Pediatric Psychology, 31(4), 356-366.  
Sears, S. R., Stanton, A. L., & Danoff-Burg, S. (2003). The yellow brick road and the emerald city: benefit 
finding, positive reappraisal coping and posttraumatic growth in women with early-stage breast cancer. 
Health Psychology, 22(5), 487-497.  
Selye, H. (1956). The stress of life. . New York: McGraw-Hill. 
93 
 
Selye, H. (1976). Stress in health and disease. Reading, MA: Buttersworth. 
Selye, H. (1982). History and present status of the stress concept. In L. Goldberger & S. Brenitz (Eds.), 
Handbook of stress; Theoretical and clinical aspects (pp. 7-17). New York: Free Press. 
Sherliker, L., & Steptoe, A. (2000). Coping with new treatment of cancer: A feasibility study of daily diary 
measures. Patient Education and Counseling, 40(1), 11-19.  
Smith, M. Y., Redd, W., DuHamel, K., Vickberg, S. J., & Ricketts, P. (1999). Validation of the PTSD 
Checklist-Civilian Version in survivors of bone marrow transplantation. Journal of Traumatic Stress, 12(3), 
485-499.  
Smith, M. Y., Redd, W. H., Peyser, C., & Vogl, D. (1999). Post-traumatic stress disorder in cancer: a 
review. Psycho-Oncology, 8(6), 521-537.  
Stanton, A. L., Bower, J. E., & Low, C. A. (2006). Posttraumatic growth after cancer. In L. G. Calhoun, . & 
Tedeschi, R. G. (Ed.), Handbook of posttraumatic growth (pp. 138 -175). Mahwah, NJ: Lawrence Erlbaum 
Associates, Inc. 
Stone, A. A., Broderick, J. E., Porter, L. S., & Kaell, A. T. (1997). The experience of rheumatoid arthritis 
pain and fatigue: Examining momentary reports and correlates over one week. Arthritis Care and 
Research, 10(3), 185-193.  
Stone, A. A., & Neale, J. M. (1982). Development of a methodology for assessing daily experiences 
Advances in Environmental Psychology: Environment and Health (Vol. 4). Hillsdale, NJ: Erlbaum. 
Stone, A. A., & Neale, J. M. (1984). Effects of severe daily events on mood. Journal of  Personality and  
Social Psychology, 46(1), 137-144.  
Stone, A. A., Reed, B. R., & Neale, J. M. (1987). Changes in daily event frequency precede episodes of 
physical symptoms. Journal of Human Stress, 13(2), 70-74.  
Sumalla, E. C., Ochoa, C., & Blanco, I. (2009). Posttraumatic growth in cancer: Reality or illusion? 
Clinical Psychology Review, 29(1), 24-33.  
Takkouche, B., Regueira, C., & Gestal-Otero, J. J. (2001). A cohort study of stress and the common cold. 
Epidemiology, 12(3), 345-349.  
Taylor, S. E. (1983). Adjustment to threatening events: A theory of cognitive adaptation. American 
Psychologist, 38(11), 1161-1173.  
Taylor, S. E., & Armor, D. A. (1996). Positive illusions and coping with adversity. Journal of Personality, 
64(4), 873-898. doi: 10.1111/j.1467-6494.1996.tb00947.x 
Tedeschi, R. G., & Calhoun, L. G. (1995). Trauma and transformation: Growing in the aftermath of 
suffering. Thousand Oaks: Sage. 
Tedeschi, R. G., & Calhoun, L. G. (1996). The Posttraumatic Growth Inventory: measuring the positive 
legacy of trauma. Journal of Traumatic Stress, 9(3), 455-471.  
Tedeschi, R. G., & Calhoun, L. G. (2004). Posttraumatic growth: Conceptual foundations and empirical 
evidence. Psychological Inquiry, 15(1), 1-18.  
Tedeschi, R. G., & Calhoun, L. G. (2004). Posttraumatic Growth: Conceptual Foundations and Empirical 
Evidence. Psychological Inquiry, 15(1), 1.  
94 
 
Tedeschi, R. G., Park, C. L., & Calhoun, L. G. (Eds.). (1998). Posttraumatic growth: Positive changes in 
the aftermath of crisis. Mahwah: Erbaum. 
Trask, P. C., Paterson, A. G., Fardig, J., & Smith, D. C. (2003). Course of distress and quality of life in 
testicular cancer patients before, during, and after chemotherapy: results of a pilot study. Psycho-Oncology, 
12(8), 814-820.  
Vermetten, E., & Bremner, J. D. (2002). Circuits and systems in stress. II. Applications to neurobiology 
and treatment in posttraumatic stress disorder. Depression and Anxiety, 16(1), 14-38.  
Vermetten, E., Vythilingam, M., Southwick, S. M., Charney, D. S., & Bremner, J. D. (2003). Long-term 
treatment with paroxetine increases verbal declarative memory and hippocampal volume in posttraumatic 
stress disorder. Biological Psychiatry, 54(7), 693-702.  
Vickberg, S. M. J., Bovbjerg, D. H., DuHamel, K. N., Currie, V., & Redd, W. H. (2000). Intrusive thoughts 
and psychological distress among breast cancer survivors: Global meaning as a possible protective factor. 
Behavioral Medicine, 25(4), 152.  
Weathers, F. W., Huska, J. A., & Keane, T. M. (1991). The PTSD Checklist - Civilian Version (PCL-C): 
Available from F.W. Weathers National Center for PTSD, Boston Veterans Affairs Medical Center, 150 S. 
Huntington Ave, Boston, MA 02130. 
Whitaker, K. L., Watson, M., & Brewin, C. R. (2009). Intrusive cognitions and their appraisal in anxious 
cancer patients. Psycho-oncology, 18(11), 1147-1155.  
Whybrow, P. C., Grof, P., Gyulai, L., Rasgon, N., Glenn, T., & Bauer, M. (2003). The electronic 
assessment of the longitudinal course of bipolar disorder: the ChronoRecord software. 
Pharmacopsychiatry, 36 Suppl 3, S244-249.  
Widows, M. R., Jacobsen, P. B., Booth-Jones, M., & Fields, K. K. (2005). Predictors of posttraumatic 
growth following bone marrow transplantation for cancer. Health Psychology, 24(3), 266-273.  
Wild, N. D., & Paivio, S. C. (2003). Psychological adjustment, coping, and emotion regulation as 
predictors of posttraumatic growth. Journal of Aggression, Maltreatment, & Trauma, 8(4), 97-119.  
Wison, J. J., Gil, K. M., Burchinal, M., Kramer, K. D., Nash, K. B., Orringer, E., et al. (1999). Depression, 
disease severity, and sickle cell disease. Journal of Behavioral Medicine, 22(2), 115-126.  
Zabora, J., Brintzenhofeszoc, K., Curbow, B., Hooker, C., & Piantadosi, S. (2001). The prevalence of 
psychological distress by cancer site. Psycho-Oncology, 10(1), 19-28.  
 
 
